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Abstract 
This thesis seeks to develop insights into how the antiviral ligand (ACV) interacts with biologically 
and medically relevant metals so as to aid future treatments of various microbial and viral diseases. 
The study focuses on synthesis of novel polymorphic structures that possess unique bonding 
patterns not otherwise seen in the literature. 
Specifically, nine single crystal structures have been obtained, derived from three different metal 
tetrafluoroborate salts: copper, zinc, silver. Both the copper and silver species were found to 
produce a range of polymorphic structures under different conditions; however, zinc produced only 
a single structure. These unique structures include a copper structure, [Cu(ACV)2(BF4)2]·ACV + 2H2O, 
that shows bonding between the counter ion (BF4
-) and the metal centre. In addition, in the silver 
structure, 2[Ag(ACV)]·SiF6 + 2H2O, a novel polymer was observed between silver and ACV.  
The potential for these metal-ACV compounds to be used in the pharmaceutical field needs further 
exploration, and is beyond the scope of this Masters project. However, this work provides a 
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1.1. Introduction 
Acyclovir (Aciclovir or ACV) is an antiviral placed on the essential medicine list by the World Health 
Organisation (WHO), [1], first discovered by the synthesis of marine sponge extracts in 1951, [2]. The 
extract found was the nucleoside deoxyguanosine (Figure 1), the precursor of acyclovir. Since its 
discovery, the acyclovir compound has been found to be an affective antiviral as a ‘prodrug’: a 
molecule that is very slightly or not at all pharmacologically active until it has metabolised with the 
virus’ or host’s system. Prior to the mainstream use of acyclovir as an antiviral, other nucleoside 
analogue antivirals were used, however, these proved to have a high cytotoxicity to them which did 
not impact the virus but placed the user in danger. However, within the second generation of 
nucleoside based antivirals, acyclovir proved not only to be safer for the patient, but was also 
extremely effective against the herpes virus (HSV-1) and infections caused by the varicella virus such 
as chicken pox and shingles, [3] leading to a future of marine sponge therapeutics, [4]. 
 
Figure 1 – the structure of a guanosine molecule. 
As previously mentioned, ACV acts as a prodrug, only becoming pharmacologically active once it is 
metabolised within the user’s system. The therapeutic breakdown of acyclovir is as a consequence 
of it being a nucleoside analogue. Key to its function is the absence of the deoxyribose group (Figure 
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2). ACV is phosphorylated by viral thymidine kinase until it is converted into ACV-TP. At this point it is 
able to be integrated into the virus’ DNA strand, acting as a chain terminator, [5]. Whilst this does 
not cure the patient of the virus, it stops the replication of the virus which is crucial for its survival 
within the host. Due to the specific kinase, ACV only targets the virus DNA. It is processed by being 
phosphorylated which is only present in viral replication enzymes. In healthy host cell DNA, the ACV 
chain terminator is less effective compared to how it behaves in viral chain termination.
 
 
Figure 2 – the structure of an Acyclovir molecule. 
Whilst the ACV only works when phosphorylated, it cannot be administered if the user is on other 
specific medication. An example of such medication would be chemotherapy and contrast agents 
(i.e. iohexol) due to the chemical components present; mutual inhibitation of the chemical processes 
of both medications can occur due to the formation of other structures that could potentially be 
harmful [6]. Another example of contraindicative medications are those for the kidneys or 
medications that are heavily extracted and processed by the kidneys. These impair the effectiveness 
of ACV as well as place a potentially dangerous stress on the renal system [6]. ACV seems to have a 
high reactivity rate which is demonstrated by how it can interact with other medications and the 
biochemistry of the patient’s body. 
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Intermolecular interactions that occur between acyclovir molecules creates ACV crystals. As 
mentioned before, ACV is a guanosine analogue and guanosine’s precursor is guanine, the 
nucleobase essential for DNA replication, [7]. Guanine is able to form layers of binding molecules to 
form crystals through π-π bonding, [8] in nature. This is observed in some animals, such as insects, 
reptiles and fish, [9] which can reflect light at different energies to give the appearance of different 
colours. Acyclovir can also stack in layers of molecules bound together, however, this does not 
produce any colour change or light interaction when in solution or as solid crystals, [10]. Given the 
fact that ACV interacts both in vivo and with itself, the possibility for ACV to interact and bond with 
other biological components, such as metals naturally occurring in the body, is highly probable. As 
previously explored, some other medications do interact with ACV by potentially inhibiting or 
modifying the structure of ACV. 
On the other hand, ACV is noted to have a very low solubility level, especially in water, [11]. This 
would suggest that ACV was not as reactive as previously believed, contradicting the observed drug-
drug interactions that could occur when taking ACV alongside other medications. In addition to 
ACV’s low solubility, is the issue of bioavailability once administered due to the variety of 
polymorphic structures ACV can exist as, [12]. Currently, to counteract this issue, higher doses are 
given or intravenous acyclovir is given to ensure that the user will receive enough of the correct 
acyclovir structure, [13]. To overcome these issues, the bioavailability of ACV would need to be 
improved, thus ensuring the correct bioactive polymorph of ACV arrives at the targeted virus’ DNA 
by thymidine kinase within the patient’s system. A potential means to achieve this would be to 
increase the solubility of ACV in aqueous environments without the need to sacrifice its neutral 
form. This would reduce the need for higher doses of ACV to be administered, due to a higher 
presence of the correct ACV structure in the solution, as previously discussed. 
Overcoming these issues of ACV would provide patients with a greater variety of treatment options 
and pathways to pursue. With an ever-increasing move away from a ‘one size fits all’ approach to 
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the treatment and care of patients [14], improvements to, and variations of, this antiviral could be as 
simple as the addition of other elements to the structure. For example, a useful addition for some 
individuals could be biological metals and minerals that are necessary for healthy day-to-day living. It 
is highly probable that those requiring acyclovir drug therapy are unlikely to be in peak physical 
health and would likely benefit from such nutritional additions. For example, copper, which is 
essential for the production and efficiency of red blood cells, may be a useful addition to the ACV 
structure, in order to avoid a deficiency in copper that could potentially lead to anaemia, [15]. 
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1.2. Literature Analysis  
To gain an insight into metal-ACV complexes, an analysis of the previous methods and structures 
present in existing literature was conducted. Garcia-Raso and e. al. discuss different transition 
metals that have been synthesised with ACV using metal chlorides, [16]. Initially, this article 
demonstrates that metal-ACV complexes can be formed with metals, (nickel, cobalt, zinc, cadmium, 
and mercury) from their corresponding chloride salt. The salt and ACV are combined in an aqueous 
solution, stirred, and crystals were obtained after 2-3 days. This report illustrates that the solubility 
issue previously encountered with ACV in water can be overcome and  coordination with metals 
centres was possible. In infrared (IR) spectroscopy, a shift in the significant C=O carbonyl group band 
on the purine ring suggests that, upon coordination to different metals, intramolecular interactions 
occur here. Compounds synthesised with nickel and cobalt both formed elongated centrosymmetric 
octahedral molecules with aqua ligands in the basal plane and ACV ligands in the axial positions 
(Figure 3). The oxygen atom from the carbonyl group forms an intramolecular hydrogen bond with 
the one of the aqua ligands.  
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Figure 3 – a molecule structure of [Ni(ACV)2(H2O)4]Cl2·2ACV, one asymmetric unit.  
The zinc complex, on the other hand, forms a tetrahedral geometry bonding to one ACV, two 
chloride atoms and a water molecule (Figure 4). However, the ACV-Zn bond is distorted, allowing for 
unique intermolecular bonding to occur between a chloride atom from one molecule to the N1 and 
N2, forming the –NH2 group of the purine ring, a novel bond type for nucleobases. Another 
intermolecular bond is observed between the hydroxyl group of the acyclic chain of ACV and the 
water ligand bonding to the zinc centre. It is observed in one asymmetric unit that there are three 
molecules of the [Zn(ACV)Cl2(H2O)] which are all bonded by intermolecular hydrogen bonds. 
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Figure 4 –a molecule structure of [Zn(ACV) Cl2 (H2O)], one asymmetric unit. 
Cadmium forms a distorted octahedral geometry complex with one ACV ligand in the basal plane 
with three chloride atom ligands, and another chloride atom in one of the axial planes. Another ACV 
ligand is found in the other axial position but is bonded by the hydroxyl (-OH) group at the end of the 
ACV tail (Figure 5). Such bonding by the hydroxyl (-OH) group was the first of its kind to be found in 
the literature reviewed. This forms an additional intramolecular bond between the carbonyl group of 
the purine ring which would increase the stability of the molecule overall. Similar to compound 3 
([Cu(ACV)4(H2O)]•2BF4), the asymmetric unit would have three cadmium-ACV complex molecules in. 
However, they form a polymeric chain, linking through a (CdCl2)n bond leading to an infinite chain. 
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Figure 5 – a molecule structure of [Cd(ACV)Cl2]·H2O, one asymmetric unit. 
In a further investigation into this uncommon bonding, a change of solvent demonstrated that in 
water, the type of bonding for copper metal was considerably different to that of methanol, forming 
instead an octahedral geometric structure. Proton NMR spectroscopy was not able to differentiate 
between the ACV acting as a bidentate ligand (Figure 7) and an octahedral structure (Figure 6) with 
hexacoordination, meaning the true structural representation is uncertain.  
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Figure 6 – a molecule structure of [Cu(ACV)2(H2O)2](NO3), in a square planar geometric shape. 
 
Figure 7 – a molecule structure of [Cu(ACV)2(H2O)2] in theoretical octahedral geometry 
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In the asymmetric unit of [Cu(ACV)2(H2O)2](NO3), there are three molecules and their accompanying 
NO3
- ions. Uniquely, the intermolecular hydrogen bonds form ribbons of the molecules, bonding at 
N2-N3 through N-H···N. N2 and N1 also use this type of bonding to the NO3
- ions as well as through 
the hydroxyl terminal group of the ACV tail. 
In addition to the analytical investigation, another approach to the complexes, is DNA binding in 
order to investigate the bioactivity and cytotoxicity of each of the metal-ACV complexes due to the 
presence of the antiviral nature of ACV. This approach was the focus of Avicioglu and Golcu’s work, 
[17]. The metal salt used in this study was chloride salt (CuCl2.2H2O, ZnCl2, FeCl3.6H2O, K2PtCl4, and 
RuCl2.3H2O) which was placed in a methanol/water solution (1/5 v/v) under a pH buffer controlled 
environment. ACV, which had already been dissolved in methanol, was added to this solution. The 
ratios of ACV were essential for the different structures of metal and ACV ligands: [Cu(ACV)Cl2], 
[Zn(ACV)Cl2]·5H2O, and [Pt(ACV)Cl2]·4H2O were all 1:1 ratio (Figure 8); [Ru(ACV)2Cl2]Cl·3H2O was in a 
2:1 ratio (Figure 9); and [Fe(ACV)3]·3Cl was in a 3:1 ratio (Figure 10).  
 
Figure 8 – the outline structure of the copper, zinc, and platinum structures, [M(ACV)Cl2].nH2O, [17]. 
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Figure 9 – One complex of [Ru(ACV)2Cl2]Cl.3H2O, [17]. 
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Figure 10 – One complex of [Fe(ACV)3]3Cl, [17]. 
Analytically, UV-Vis spectroscopy, IR spectroscopy, mass spectrometry, thermal analysis, and proton 
NMR spectroscopy  all featured in these articles. The UV-Vis spectroscopy found that all complexes 
had a d→d* transition between 437-492 nm except for the platinum and zinc compounds. All 
complexes had Metal → Ligand charge transfer transitions and Ligand→ Metal charge transfer 
transitions , as well as n → π* and π → π* transitions.  The conclusion of the geometry of the 
ruthenium and iron was that it formed octahedral structures, while platinum and copper formed 
square planar and zinc formed tetrahedral. IR spectroscopy found that all metal-ACV complexes’ 
spectra were similar to that of the pure ACV spectrum with the exception of the C=O carbonyl group 
in each complex. The bonding of the carbonyl to the metal impacted the π bond interaction which 
gave a slightly altered IR reading. Thermal analysis found all complexes had ‘absorbed and/or 
hydrated water molecules’ present, except copper and iron [17]. . Water coordinated to metal was 
found to have been eliminated in the range of 100-250°C and at 250-500°C the ‘elimination of one, 
two or three coordinated chloride ions’ [17] occurred leaving the metal-ACV species. Mass 
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spectroscopy found the molecular ions peaks and fragmentations expected in each compound. 
However, the proton NMR spectra had difficultly differentiating between the non-paramagnetic 
complexes, in particular the platinum and zinc compounds where there were only some small 
differences, leading to inconclusive data.  
A key difference in Avicioglu and Golcu’s study when compared to others was the incorporation of 
antimicrobial and antiviral tests. In the antimicrobial studies, each metal-ACV complex was 
introduced to certain strains of bacterium and fungi, and would be judged on the inhibition area size 
it created. It was found that only [Pt(ACV)Cl2]·4H2O showed a high effectiveness against two fungi 
microbials, but none of the bacteria samples. The antiviral study demonstrated that all compounds 
were effective against viruses. When diluted, all but iron still had effective cytotoxicity up to and 
including 1/1024 dilution rate; [Fe(ACV)3]·3Cl was only effective up to and including 1/512 dilution 
rate.  
All compounds synthesised in Avicioglu and Golcu’s study showed a strong binding ability to DNA, 
being replaced with guanine ligands in vivo. The study acknowledges the potential for the use of 
Metal-Ligand compounds to be extended beyond antimicrobial or antiviral, such as biomarkers for 
medical investigations [17].  
Another paper by Iztok Turel explores the possible complexes with ruthenium(III)-DMSO in solution, 
solid state and the biological characterisation of each with purine base derivatives, one of which is 
ACV, [18]. The initial synthesis was [(DMSO)2H] [trans-RuCl4(DMSO)2] and ACV added to dried 
ethanol in a 2:1 ratio taking 14 days to obtain a small amount of orange needle like crystals which 
were suitable for single crystal XRD. These crystals were characterised as                                                           
[mer-RuCl3(ACV)(DMSO)(C2H5OH)].C2H5OH in an octahedral geometric structure (Figure 11). This 
compound is similar to a new anti-tumour metastasis inhibitor (NAMI) used currently as an 
anticancer drug, [19]. The hydrogen bond acceptor (C2H5OH) replacing one of the DMSO from the 
reactant precursor allows the bonding between ruthenium and the ACV ligand via N7. Methanol 
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([mer-RuCl3(ACV)(DMSO)(CH3OH)].0.5CH3OH) or water ([mer-RuCl3(ACV)(DMSO)(H2O)].H2O) could 
also have been used as the hydrogen bond acceptor. 
 
 
Figure 11 – a molecule structure of [mer-RuCl3(ACV)(DMSO)(C2H5OH)].C2H5OH. 
However, in a 4.5:1 ratio of (NH4) [trans-RuCl4(DMSO)2] and ACV, in a mixture of ethanol and 
hydrochloric acid (1M) (1/1 v/v) that was left for three hours under reflux, red crystals were 
deposited. Once filtered, washed with diethyl ether and dried, the crystals were analysed by single 
crystal XRD which showed that it had synthesised to [trans-RuCl4(guaH)(DMSO)].2H2O in an 
octahedral structure; ACV had been substituted for guaninium (guanH). This too is similar to NAMI 
agents that are currently being used to treat cancer. The IR spectra taken from both compounds 
were similar to each other, but [trans-RuCl4(guaH)(DMSO)].2H2O showed another peak at 1704 cm
-1 
for the carbonyl group. The obvious difference between compounds [mer-
24 | P a g e  
 
RuCl3(ACV)(DMSO)(C2H5OH)].C2H5OH and [trans-RuCl4(guaH)(DMSO)].2H2O is that [trans-
RuCl4(guaH)(DMSO)].2H2O  has the carbonyl group facing away from the centre of the molecule 
whereas  the carbonyl group present in [mer-RuCl3(ACV)(DMSO)(C2H5OH)].C2H5OHis facing inwards, 
forming an intramolecular bond. This has caused the loss of the peak in the IR spectrum for [mer-
RuCl3(ACV)(DMSO)(C2H5OH)].C2H5OH. The explanation for the carbonyl group facing outwards from  
the centre is the loss of the acyclic tail due to the acidic conditions, pronating the N7 to form 
guaninium, but bonding to the ruthenium through N9. This Ru-N bonding leads to intramolecular 
bonding: N-H---Cl, as no chloride ion has to be substituted. 
Although [mer-RuCl3(ACV)(DMSO)(C2H5OH)].C2H5OH, [mer-RuCl3(ACV)(DMSO)(CH3OH)].0.5CH3OH 
and [mer-RuCl3(ACV)(DMSO)(H2O)].H2O bond by N7 to the metal centre, which is more favourable in 
a neutral pH environment, there are no intramolecular bonds with the chloride atoms in the centre. 
There is an intramolecular hydrogen bond between O6 (carbonyl group) and O1e (oxygen of the 
bonded ethanol group), as previously mentioned in Figure 11, present in all three of these 
compounds. In [trans-RuCl4(guaH)(DMSO)].2H2O there is a distorted octahedral structure with 
chloride atoms in the equatorial plane. The DMSO and guaninium ligand is bonded in the axial 
planes. The guaninium N9 bonds to the ruthenium atom obtaining the shortest bond amongst all of 
the compounds in this study. In addition to the short and strong Ru-N bond, the C=O in [trans-
RuCl4(guaH)(DMSO)].2H2O is  shorter than that found in compounds [mer-
RuCl3(ACV)(DMSO)(C2H5OH)].C2H5OH, [mer-RuCl3(ACV)(DMSO)(CH3OH)].0.5CH3OH  and [mer-
RuCl3(ACV)(DMSO)(H2O)].H2O which is explained by the rare form of bonding. Turel et al. comment 
on the ‘relatively rare’ [18] coordination of guaninium to ruthenium through N9. The position that 
the guaninium takes when bonding to the ruthenium allows intramolecular hydrogen bonding 
between N3 and the chloride atoms as they have not been substituted, as is the case  in the other 
compounds, leading to an energetically more favourable compound. 
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UV-Vis spectroscopy was used to analyse both [trans-RuCl4(guaH)(DMSO)].2H2O and [mer-
RuCl3(ACV)(DMSO)(H2O)].H2O. [trans-RuCl4(guaH)(DMSO)].2H2O had a 5% decrease in the UV-Vis 
data, at 395 nm, after four hours owing to hydrolysis of the DMSO. This decreased further as the 
wavelength dropped from 351 nm to 336 nm as the release of a chloride atom occurred. A similar 
observation was made in [mer-RuCl3(ACV)(DMSO)(H2O)].H2O, however, this occurred a lot faster, 
happening in 40 minutes, due to this complex having less chloride atoms than [trans-
RuCl4(guaH)(DMSO)].2H2O  which, as previously explained, has a stronger intramolecular bond 
framework. 
Biological tests of compounds [trans-RuCl4(guaH)(DMSO)].2H2O, [mer-
RuCl3(ACV)(DMSO)(CH3OH)].0.5CH3OH  and [mer-RuCl3(ACV)(DMSO)(H2O)].H2O against 
adenocarcinoma cells showed fairly similar results. [trans-RuCl4(guaH)(DMSO)].2H2O initially 
inhibited 12% of the cells in 24 hours, increasing to 35% in 48 hours, but then disappears after 72 
hours. [mer-RuCl3(ACV)(DMSO)(CH3OH)].0.5CH3OH begins higher than [trans-
RuCl4(guaH)(DMSO)].2H2O  at 38% in 24 hours, however, this plateaus at 48 hours, and is then 
partially lost after 72 hours. Finally, [mer-RuCl3(ACV)(DMSO)(H2O)].H2O inhibits 25% of the cells in 24 
hours, rising to 30% in 48 hours. However, consistent with the other two compounds, after 72 hours 
it is completely lost. Nevertheless, [trans-RuCl4(guaH)(DMSO)].2H2O allowed cells more uptake of 
ruthenium than the other two compounds, even though it was not the most effective in inhibiting 
the cells. Although the ruthenium in [mer-RuCl3(ACV)(DMSO)(CH3OH)].0.5CH3OH  and [mer-
RuCl3(ACV)(DMSO)(H2O)].H2O was absorbed into  the cells, it was less effective than [trans-
RuCl4(guaH)(DMSO)].2H2O; [trans-RuCl4(guaH)(DMSO)].2H2O absorbed 89% of the ruthenium, 
compared to 18.5% by [mer-RuCl3(ACV)(DMSO)(CH3OH)].0.5CH3OH and 11.7% by [mer-
RuCl3(ACV)(DMSO)(H2O)].H2O  [18] (Figure 12). 
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Figure 12 – ruthenium uptake from [trans-RuCl4(guaH)(DMSO)].2H2O (2), [mer-RuCl3(ACV)(DMSO)(CH3OH)].0.5CH3OH (3) 
and [mer-RuCl3(ACV)(DMSO)(H2O)].H2O (4) into adenocarcinoma cells, [18]. 
  
27 | P a g e  
 
1.3. Aims 
The synthesis of new metal-ACV structures, with the potential to form structures that can be used in 
future studies regarding their use in the biochemical and/or the medical field, is necessary to 
develop patient treatments for viral conditions, such as complications with the herpes virus. This 
study aims to synthesise, observe and classify novel metal-ACV molecules, in particular: copper, zinc 
and silver. Different crystallisation methods will be used and observations made in either solid or 
solution state prior to classification through x-ray diffraction. 
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2. Experimental 
2.1. Synthesising Single Crystals of 1-9 
2.1.1. General Method 
Metal (Cu2+, Zn2+, Ag+) tetrafluoroborate salt and acyclovir (ACV) were added in the appropriate 
ratio (vide infra, Table 1, Table 2 and Table 3) to a glass vial and methanol or ethanol (5-7 mL) was 
added. The solution was briefly sonicated (<1 minute) with heating to aid dissolution. Vials were left 
open and allowed to slowly evaporate. Before complete evaporation, crops of single crystals formed 
that were isolated by taking them out with a spatula and placing them in a new glass vial and 
analysed initially by single crystal X-ray diffraction (SCXRD) methods, followed by powder X-ray 
diffraction (PXRD), infrared (IR) spectroscopy, and scanning electron microscopy/energy-dispersive 
X-ray (SEM/EDX). The vials were later sealed. 
2.1.2. Equipment and Chemicals 
The ligand (Acyclovir) used in this study was purchased from Sigma Aldrich as a bulk stock. The 
product’s CAS number is 59277-89-3 and has 100% assay; IR (cm-1): 1695, 1647, 1575, 1541, 1489, 
1477, 1419, 1386, 1361, 1340, 1307, 1226, 1182, 1103, 1047, 1014. The metal salts used were also 
bought from Sigma Aldrich: silver tetrafluoroborate (CAS: 14104-20-2, 98%), copper 
tetrafluoroborate (CAS: 207121-39-9) and zinc tetrafluoroborate (CAS: 27860-83-9). All metal 
tetrafluoroborates are hazardous, corrosive and are irritants, which may cause severe burning and 
irritation to the respiratory system. 
2.1.3. Copper Compounds 1-5 
As per the general method, copper tetrafluoroborate [Cu(BF4)2] (~10 mg, 0.042 mM) and ACV (~10 
mg, 0.044 mM) were added to a 7 mL glass vial. The solvent was then added and the solution was 
fully mixed. After evaporation, between 4-6 days, a majority of crystals were green in colour, 
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however, some were colourless in appearance. Green crystals were selected for SCXRD analysis as 
these crystals were certain to have reacted. 
Other solutions including copper were also made. By varying the metal to ligand ratio of copper 
tetrafluoroborate and ACV, increasing the ligand to 20 mg and 30 mg in solutions. The final 
conditions are stated in Table 1. 
Table 1: Summary of conditions for synthesis of copper complexes 1-5 
Compound Formula Mol. of Cu(BF4)2 
/ mM 






1 [Cu(ACV)2(H2O)3]•2BF4 0.44 0.88 Methanol Evaporation Green Blocks 
2 [Cu(ACV)2(H2O)2(OH)2]•ACV + 
H2O 
0.44 0.88 Ethanol Evaporation Light Green 
Plates 
3 [Cu(ACV)4(H2O)]•2BF4 0.44 0.44 Ethanol Evaporation Green Blocks 
4 [Cu(ACV)2(H2O)2]•BF4 0.44 0.44 Acetone Evaporation  Green Needles 
5 [Cu(ACV)2(BF4)2]•ACV      
+ H2O 









Figure 13 – the molecule structure of complex 1: [Cu(ACV)2(H2O)3]•2BF4 labelled. 
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2: [Cu(ACV)2(H2O)2(OH)2]•ACV + 2H2O 
 
Figure 14 – the molecule structure of complex 2:[Cu(ACV)2(H2O)2(OH)2]•ACV + 2H2O labelled. 
3: [Cu(ACV)4(H2O)]•2BF4 
 
Figure 15 – the molecule structure of complex 3:[Cu(ACV)4(H2O)]•2BF4 labelled.  




Figure 16 – the molecule structure of complex 4: [Cu(ACV)2(H2O)2]•2BF4 labelled. 
5: [Cu(ACV)2(BF4)2]•ACV + 2H2O 
 
Figure 17 – the molecule structure of complex 5: [Cu(ACV)2(BF4)2]•ACV + 2H2O labelled. 
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2.1.4. Zinc Compound 6 
A zinc compound was synthesised according to the general method. Zinc tetrafluoroborate (Zn(BF4)2) 
(~10 mg, 0.042 mM) and ACV (~10 mg, 0.044 mM) were added to a glass vial. The solvent was then 
added and the solution was fully mixed (Table 2). After evaporation, between 5-7 days, selected 
clear, colourless crystals were picked for SCXRD analysis. 
Other solutions were also made, however, when the ratio of metal to ligand was changed by 
increasing ACV to 20 mg and 30 mg, no change in motif was observed.  
Table 2: Summary of conditions for synthesis of zinc complex 6 
Compound Formula Mol. of Zn(BF4)2 
/ mM 
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6: [Zn(ACV)4]•SiF6 + H2O 
 
Figure 18 – the molecule structure of complex 6: [Zn(ACV)4]•SiF6 + H2O labelled. 
2.1.5. Silver Compounds 7-9 
As per the general method, silver tetrafluoroborate (AgBF4) (~8 mg, 0.044 mM) and ACV (~10 mg, 
0.044 mM) were added to a glass vial and wrapped in aluminium foil to prevent the light sensitive 
silver from reducing. The solvent was then added and the solution was fully mixed (Table 3). After 
evaporation, selected clear, colourless crystals were picked for SCXRD analysis. 
Other solutions were also made, however, the ratio of metal to ligand was changed, with ACV 
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Table 3: Summary of conditions for synthesis of silver complexes 7-9 
Compound Formula Mol. of AgBF4 
/ mM 






0.44 0.44 Methanol Evaporation 
8 2[Ag (ACV)]•SiF6 
+ 2H2O 
0.44 0.44 Ethanol Evaporation 
9 2[Ag(ACV)2]•SiF6 
+ 2H2O 
0.44 0.88 Ethanol Evaporation 
 
7: 2[Ag2(ACV)3]•2SiF6 + 3H2O 
 
Figure 19 – the molecule structure of complex 7: 2[Ag2(ACV)3]•2SiF6 + 3H2O labelled. 
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8:  2[Ag(ACV)]•SiF6 + 2H2O 
 
Figure 20 – the molecule structure of complex 8: 2[Ag(ACV)]•SiF6 + 2H2O labelled. 
9: 2[Ag(ACV)2]•SiF6 + 2H2O 
 
Figure 21 – the molecule structure of complex 9: 2[Ag(ACV)2]•SiF6 + 2H2O labelled. 
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2.1.6. Scaling Up the synthesis of 1-9 
For further analysis, the crystallisations were scaled up by a factor of 10 to isolate more material to 
enable analysis by Powder X-Ray Diffraction (PXRD). Therefore, the metal salt (100 mg, 4.44 mM) 
and ACV (100 mg, 4.44 mM) were added to a vial and solvent added (as referenced in Tables 1, 2, 
and 3). Heating and sonication was applied to assist the reaction. 
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2.2. Synthesising Powder Samples 
2.2.1. General Method 1 – Evaporation  
All syntheses relating to this method were carried out as described below, unless stated otherwise. A 
range of solvents were used in this method: methanol (MeOH), ethanol (EtOH), acetonitrile (MeCN) 
and acetone (AcO). Metal (Cu2+, Zn2+, Ag+) tetrafluoroborate (4.44 mM) and Acyclovir (100 mg, 4.44 
mM) were added to a 10 mL glass vial. The selected solvent was then added to the glass vial (7 mL). 
The sample was sonicated for <1 minute and heated to promote dissolution and reaction. The 
solution was then filtered through a plug of cotton wool and Celite® 545. After filtration was 
complete, the vial containing the solution was covered with parafilm and a small hole made in the 
top to allow slow evaporation. 
2.2.2. General Method 2 – Layering 
A range of solvents were used in this method: methanol (MeOH), ethanol (EtOH), acetonitrile 
(MeCN), and acetone (AcO). Metal Salt (4.44 mM) and Acyclovir (100 mg, 4.44 mM) were added to a 
10 mL glass vial. The solvent was added to the glass vial (7 mL). The sample was sonicated for <1 
minute and heated to promote dissolution and reaction. The solution would then be filtered through 
a glass pipette containing cotton wool and Celite® 545. In a separate clean glass vial a layer of 
dichloromethane (DCM) (~1 mL, 0.01 M) was placed. A 1:1 buffer solution (~2 mL) of DCM and the 
chosen solvent was then slowly layered on top of the DCM using a 1mL needle and syringe to 
deposit it down the side of the vial. Finally, the metal/ligand solution (~1 mL) was layered on top of 
the buffer by needle and syringe and a cap would be screwed on top to prevent solvent evaporation. 
Over time, the three layers slowly combined, resulting in crystallisation of the complex. 
2.3. Synthesis of 1 ([Cu(ACV)2(H2O)3]•2BF4) 
Both general methods 1 and 2 were used to synthesise this product. Two ratios were used when 
producing these samples: 1:1 and 2:1 ligand to metal. The synthesis of the 1:1 sample is as described 
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in the general methods. The 2:1 sample was created by ACV (200 mg, 0.88 mM) and Cu(BF4)2 (100 
mg, 0.44 mM) being added to a vial, after which a chosen solvent was added to the vial. Both 
heating and sonication was used to aid reaction. Both the evaporation method and layering method 
were then used. The final product synthesised by the evaporation method was green blocks 
indicating the 2:1 ratio to be the most effective approach. IR (cm-1): 1697, 1635, 1589, 1541, 1490, 
1419, 1363, 1178, 1080, 1051, 1010. However, once the measured PXRD data was compared to the 
predicted (Appendix A Fig.1), the pattern showed the sample to be largely consist of copper complex 
1. 
2.4. Synthesis of 2 ([Cu(ACV)2(H2O)2(OH)2]•ACV + 2H2O) 
Both general methods 1 and 2 were used to synthesise this product. Two ratios were used when 
producing these samples: 1:1 and 2:1 ligand to metal. The synthesis of the 1:1 sample is as described 
in the general methods. The 2:1 sample was created by adding ACV (200 mg, 0.88 mM) and Cu(BF4)2 
(100 mg, 0.44 mM) to a vial and a chosen solvent would be added to the vial. Both heating and 
sonication was used to aid reaction. Both the evaporation method and layering method were then 
used. Evaporation proved to be the better method with a 2:1 ratio of ligand to metal which 
produced light green plates with a visibly larger yield. IR (cm-1): 1697, 1635, 1589, 1541, 1490, 1419, 
1363, 1178, 1080, 1051, 1010. When analysing the PXRD comparison between the predicted Cu 2 
and the product (Appendix A Fig.2), the pattern showed the sample to largely consist of copper 
complex 2. 
2.5. Synthesis of 3 ([Cu(ACV)4(H2O)]•2BF4) 
Both general methods 1 and 2 were used to synthesise this product. Three ratios were used when 
producing these samples: 1:1, 2:1 and 3:1 ligand to metal. The 1:1 sample is as described in the 
general methods. The 2:1 sample was created by adding ACV (200 mg, 0.88 mM) and Cu(BF4)2 (100 
mg, 0.44 mM) and a chosen solvent to the vial. The 3:1 sample was created by adding ACV (3:1, 300 
mg, 1.33 mM) and Cu(BF4)2 (100 mg, 0.44 mM)  and a chosen solvent to the vial. Both heating and 
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sonication was used to aid reaction. Both the evaporation method and layering method were then 
used. The evaporation method was more effective in a 1:1 ratio which showed green block crystals 
which, compared to the other samples, gave a larger yield. IR (cm-1): 1689, 1655, 1598, 1490, 1425, 
1359, 1346, 1290, 1274, 1257, 1219, 1193, 1132, 1093, 1047, 1002. The PXRD comparison showed a 
similar pattern in both the measured and the predicted data, hence this species is the dominant 
product. 
2.6. Synthesis of 4 ([Cu(ACV)2(H2O)2]•2BF4 ) 
As per general method 1, this sample was replicated to form a sufficient sample to perform the 
analytical techniques PXRD and infrared spectroscopy. The solvent used in this sample was limited to 
acetone, as the single crystal was formed from copper and acyclovir in acetone. Both ratios 1:1 and 
2:1, ligand to metal, were used in the synthesis. For example, the 2:1 product would be formed from 
Cu(BF4)2 (100 mg, 0.44 mM) and ACV (200 mg, 0.88 mM) in a vial, then acetone (~5 mL, 0.08 mM) 
was added. Heating and sonication was used to assist the reaction process. Although method 1 was 
predominantly chosen for the better yield and better quality crystals, which were dark green 
needles, a layered approach was also undertaken. The PXRD comparison data can be seen in 
Appendix A Fig.4 and Fig. 5 which demonstrate that the evaporation approach provides better bulk 
material of Cu 4. IR (cm-1): 1685, 1653, 1598, 1544, 1489, 1357, 1346, 1193, 1132, 1095, 1045, 1004. 
2.7. Synthesis of 5 ([Cu(ACV)2(BF4)2]•ACV+ 2H2O) 
Cu 5 was synthesised by both general methods 1 and 2 to increase the likelihood of achieving single 
crystals. Using ethanol as the solvent to achieve Cu 5, the crystals synthesised using the evaporation 
method were of a higher quantity and quality. For Cu 5, a 1:1 ratio was used: ACV (100 mg, 0.44 
mM) and Cu(BF4)2 (100 mg, 0.44 mM) were added to a vial along with ethanol (~5 mL, 1 mM). 
Heating and sonication was needed to promote a full reaction. Overall, evaporation was a better 
method for producing Cu 5 crystals which were dark green bunched needles. IR (cm-1): 1689, 1655, 
1598, 1490, 1425, 1359, 1346, 1290, 1274, 1257, 1219, 1193, 1132, 1093, 1047, 1002. The 
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comparative PXRD data (Appendix A, Fig. 6) show both the measured and the predicted data to be 
mainly low intensity peaks with considerable similarities. Some differences were however seen, such 
as at ~27 θ there is a double peak in the measured data that only appears as a single peak in the 
predicted data. Additionally, there is a large stacked peak at ~34 θ in the measured data which is not 
in the predicted; these differences suggest that there may be a mixture of polymorphs within the Cu 
5 sample. 
2.8. Synthesis of 6 ([Zn(ACV)4]•SiF6+ H2O) 
The zinc compound was synthesised by both general methods 1 and 2. All solvent options were 
explored to achieve this particular crystal. Ligand to metal ratios 1:1 and 2:1 were used. ACV (100 
mg/200 mg, 0.44 mM/0.88 mM), Zn(BF4)2 (100 mg, 0.44 mM) and Na2SiF6 (~7 mg, 0.44 mM) were 
added to a vial and the solvent (~5mL) added. This solution was sonicated and heated to aid the 
reaction. In order to achieve a yield of crystals, the only method that was found to effectively 
synthesise a product was layering in a 2:1 ratio of ligand to metal which resulted in cloudy, white 
blocks. IR (cm-1): 1691, 1653, 1647, 1637, 1577, 1541, 1489, 1477, 1419, 1386, 1363, 1340, 1311, 
1226, 1182, 1045. The PXRD comparison of the measured and the predicted data (Appendix A, Fig.7) 
demonstrated a largely similar pattern and intensity of peaks. However, low crystallinity/amorphous 
nature hindered matching of this sample. 
2.9. Synthesis of 7 (2[Ag(ACV)3]•SiF6+ 3H2O) 
Crystals of Ag 1 were synthesised by general methods 1 and 2. A range of solvents were trialled to 
form this particular crystal. Ratios 1:1, 2:1 and 3:1 of ligand to metal were used. ACV (80 mg/160 
mg/240 mg, 0.44 mM/0.88 mM/1.3 mM), AgBF4 (100 mg, 0.44 mM) and Na2SiF6 (~7 mg, 0.44 mM) 
were added to a vial along with the solvent (~5mL). This solution was sonicated and heated to aid 
the reaction. Evaporation was the best method for Ag 1 in a 1:1 ratio which gave colourless plated 
crystals which, when left exposed to air, became very tacky, suggesting hygroscopic behaviour. IR 
(cm-1): 1693, 1629, 1577, 1539, 1477, 1386, 1361, 1340, 1311, 1226, 1182, 1045, 1016, 985. The 
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PXRD data comparing the measured data and the predicted data indicated some strong similarities 
in the powder patterns (Appendix A, Fig. 8). However, a low crystallinity/amorphous nature hindered 
matching of this sample. 
2.10. Synthesis of 8 (2[Ag(ACV)]•SiF6+ 2H2O) 
The Ag 2 crystal was synthesised by general methods 1 and 2. A range of solvents were trialled 
separately to form this particular crystal with two ligand to metal ratios, 1:1 and 2:1, tested. ACV (80 
mg/160 mg, 0.44 mM/0.88 mM), AgBF4 (100 mg, 0.44 mM) and Na2SiF6 (~7 mg, 0.44 mM) were 
added to a vial along with the solvent (~5mL). This solution was sonicated and heated to aid the 
reaction. When synthesising the Ag 2 crystal, the best method for yield and quality was by 
evaporation in a 1:1 ratio, forming colourless crystal plates which, when left exposed to air, would 
become tacky. IR (cm-1): 1693, 1629, 1577, 1539, 1386, 1361, 1311, 1226, 1182, 1045, 1016. The 
PXRD data comparing the measured and predicted data was inconclusive as the measured data was 
highly amorphous (Appendix A, Fig. 9) and therefore did not show many analytical peaks.  
2.11. Synthesis of 9 (2[Ag(ACV)2]•SiF6+ 2H2O) 
Ag 3 was synthesised by general methods 1 and 2 with a range of solvents used in separate trials to 
form this crystal. Two different ratios of ligand to metals were used: 1:1 and 2:1. ACV (80 mg/160 
mg, 0.44 mM/0.88 mM), AgBF4 (100 mg, 0.44 mM) and Na2SiF6 (~7 mg, 0.44 mM) were added to a 
vial along with the solvent (~5 mL). This solution was sonicated and heated to aid the reaction. 
Evaporation method with a 2:1 ratio of ligand to metal was used and synthesised colourless crystal 
plates which, when left exposed to air, would become tacky. IR (cm-1): 1693, 1629, 1577, 1539, 1386, 
1361, 1311, 1226, 1182, 1045, 1016. Comparative PXRD showed that the measured data line shows 
broad similarities to the predicted data pattern (Appendix A, Fig. 10). However, as with the other 
silver complexes, the somewhat amorphous nature of the samples prevents unambiguous matching. 
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3. Results and Discussion 
3.1. Acyclovir (ACV) (Ligand) 
 
Figure 22 – labelled stick and ball model of acyclovir ligand. 
Acyclovir has been used as a ligand in this study. It consists of a neutral, purine ring with an attached 
ethylene glycol tail, C6-O3 (to be further referred to as the ‘tail’) (Figure 22). The majority of the 
bonding with the metal occurs at the 5-membered ring at N4, with other examples bonding at O1 
and N3 (Figure 23), [16]. 




Figure 23 – Metal (M) bonding to N4 (i), N4 and O1 (ii), and N3 (iii) in metal-ACV complexes. Within this study, these are 
the three outcomes of the metal to ligand bonding. 
The binding modes shown in Figure 23 were all observed in this work, in which the metal ion (M) 
corresponds to Cu2+, Zn2+ or Ag+. In Figure 23(i), the metal ion is seen to bond with one of the 
nitrogen atoms of ACV in the 5 membered ring, N4. In Fig.23 (ii) and Fig. 23(iii), the metal bonds at 
other points of the acyclovir ligand whilst simultaneously bonding with N4. Examples of the N4 
bonding have been seen in other research work. A study by Garcia-Raso et al. into the structural 
synthesis and characteristics of metal-acyclovir including Nickel, Zinc, and Cadmium, all of which 
bonded to the acyclovir ligand by N4, [16]. 




Figure 24 – sheets of acyclovir bonded together through N2-H···O1, N1- H···N4 and O3-H···N8 hydrogen bonds at the 
purine rings. Not all Hydrogen atoms are shown. 
Acyclovir can form in sheets where the molecules assemble with tail up then tail down, alternating 
between up and down (Figure 24). The sheets are constructed from two hydrogen bonds; N2-H···O1 
and N1-H···N4 allow acyclovir molecules to link into sheets. To facilitate stacking, the tails of ACV 
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3.1.3. Predicted Infrared Bands 
 
Figure 25 – Functional groups (A-F) that would give infrared absorption data of Acyclovir. 
Functional groups A-F (Figure 25) were used when assigning infrared bands for all metal-ACV 
compounds or ACV. The (-OH)(A) bond is expected to show a broad band between 3550-3200 cm-1. 
The (C=O)(B) in the aromatic ring would display a medium peak 1725-1695 cm-1 which is hoped to be 
a diagnostic band for complex formation. The amine group, (NH2)
(C), would show another broad 
peak, in the region of 3350-3310 cm-1, that would be combined with the (-OH) band previously 
mentioned. The carbon nitrogen bonds, (C=N)(D) and (C-N)(E), would both have medium intensity 
peaks at 1690-1640 cm-1 and 1350-1000 cm-1 respectively. Finally, there would be another peak that 
would be attributed to the ether group in the tail of the acyclovir ligand (C-O-C)(F) at 1150-1085 cm-1. 
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Figure 26 – the experimental IR Spectrum of ACV.   
Figure 26 shows the observed infrared spectrum of ACV, taken on the same instrument as the other 
samples. The red blocks are all significant data points that incorporate data that falls within the 
ranges previously described. The data points that have specific Figures attached are to show the 
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3.2. Copper Complexes 1-5 
3.2.1. 1 [Cu(ACV)2(H2O)3]•2(BF4) 
 
Figure 27 – crystal 1: [Cu(ACV)2(H2O)3]•2(BF4) labelled 
The copper centre adopts the square pyramidal formation comprised of five coordinated ligands, 
three aqua ligands and two ACV ligands. The single copper centre is coordinated by oxygen atoms 
(O7, O8 and O11) (Figure 27) from three water molecules. The acyclovir ligands coordinate to the 
metal via the identical nitrogen location on the five membered ring (N5 and N6), the binding mode 
seen in Figure 23(i). All ligands attached to the copper ion, both the waters and the acyclovir ligands, 
are neutral in charge with the metal charge balanced by two tetrafluoroborate anions.  
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3.2.2. Bond Angles 
 
Figure 28 – The angles of the ligand-metal-ligand in the equatorial plane of [Cu(ACV)2(H2O)3]•2(BF4). 
The angles that the ligands form within the square base of the pyramid formation are shown in 
Figure 28: (N5-Cu1-N6) 93.14(1)°; (N6-Cu1-O7) 92.48(1)°; (O7-Cu1-O8) 87.20(9)°; (O8-Cu1-N5) 
87.32(1)°. While square pyramidal should follow a ≤90° pattern, these angles are only slightly 
distorted and are approaching the expected bond angles of a square pyramidal formation. 
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Figure 29 – bond angles from each of the equatorial atoms to O11 of [Cu(ACV)2(H2O)3]•2(BF4). 
The angles from all the atoms in the equatorial plane to the axial plane (O11) are as follows: (N5-
Cu1-O11) 90.61(1)°, (N6-Cu1-O11) 90.16(1)°, (O7-Cu1-O11) 108.16(9)° and (O7-Cu1-O11) 89.46(9)° 
(Figure 29). 
Angle (O8-Cu1-N5) was the smallest angle in the equatorial plane, possibly due to the steric 
repulsion of the two ACV ligands, or interaction with the water solvents or counter ion, BF4
-. This 
interaction would have caused an effect on the spacing of the other coordinating ligands which is 
why the angles are not all 90° or nearer.  
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3.2.3. Bond Distances 
 
Figure 30 – the bond distances from the bonding ligand atoms and the metal centre of [Cu(ACV)2(H2O)3]•2(BF4). 
The lengths of the equatorial bonds: (Cu1-O8) 1.978(2) Å; (Cu1-O7) 1.955(2) Å; (Cu1-N6) 2.014(3) Å; 
and (Cu1-N5) 1.989(3) Å, were all shorter than the axial bond: (Cu1-O11) 2.218(3) Å (Figure 30).  
From all of the images of crystal 1, it is possible to describe the complex as a cis model [20]. The 
square pyramidal formation has what can be described as a square planar around the middle of the 
complex, with two different ligand types: two acyclovir and two water molecules. Both the water 
molecules are located on the same side of the complex when viewed down the Z axis and both 
acyclovir ligands are cis to each other. 
In addition to the cis model, the tails of the acyclovir ligands are oriented in different directions. The 
acyclovir with N30 atom travels through the medial plane whereas, the acyclovir with N13 atom 
travels through the vertical plane. 
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3.2.4. Unit Cell, Intermolecular and Intramolecular Bonding 
 
Figure 31- one cell unit of [Cu(ACV)2(H2O)3]•2(BF4), viewed from the a plan.  
The asymmetric unit fits only a quarter of the unit cell given its space group of P21/n (monoclinic). 
The two single crystals in the centre of the axes have the O11 atom facing in opposite directions to 
each other, with one of the acyclovir tails facing up in the Y axis whilst the other tail faces down the 
Y axis (Figure 31). This would likely have happened in order to minimise the energy between each 
molecule and facilitate intermolecular interactions. However, the remaining two copper complexes 
to the left and right of the central complexes face into the centre, allowing each of their tails to fill 
voids that would otherwise be filled by solvent, or counter anions. The remaining voids are also filled 
by methanol or tetrafluoroborate anions. 
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Figure 32 – Selected intermolecular forces in a crystal 1 packed crystal between N3-H···O4, N10-H···O1, O6-H···O3, O11-
H···O3, O7-H···N2 and O8-H···O5 (Note: hydrogen atoms not displayed). 
Intermolecular forces observed between Cu 1 components are hydrogen bonds, formed from 
nitrogen-oxygen or oxygen-oxygen donor/acceptor interactions (see Figure 32). There are six unique 
hydrogen bonding interactions that take place and their corresponding bond distances and angles 
are as follows: N3-H···O4 (2.845(3) Å), N10-H···O1 (3.059 Å), O6-H···O3 (2.783 Å), O11-H···O3 (2.704 
Å), O7-H···N2 (2.798 Å) and O8-H···O5 (2.815 Å) (see Table 1). All of the hydrogen bond lengths fall 
within the moderate strength region of 2.5-3.2 Å [21], demonstrating that the hydrogen bonding 
within the crystal is a dominant solid-state stabilising force. 
 
 




    






3 Angle / °  
N3 O4 2.845(3) 
 
N3 H3A O4 168.4(18) 
H3A O4 1.997(19) 
 
N10 H10A O1 160(2) 
N10 O1 2.891(3) 
 
O6 H6 O3 162.1(19) 
H10A O1 2.067(17) 
 
O11 H11B O3 152.6(17) 
O6 O3 2.783(3) 
 
O7 H7A N2 124.6(19) 
H6 O3 1.991(2) 
 
O8 H8A O5 143.3(17) 
O11 O3 2.704(4) 
     H11B O3 1.889(3) 
     O7 N2 2.798(3) 
     H7A N2 2.216(3) 
     O8 O5 2.815(3) 
     H8A O5 2.078(2) 
     Table 1 – all of the intermolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angles from [Cu(ACV)2(H2O)3]•2(BF4). 
 
Figure 33 – intramolecular bonding in a single crystal molecular between O7-H···O4 (Note: hydrogen atoms not 
displayed.) 
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Within a molecule of Cu 1, there were intramolecular hydrogen bonds between O4-H···O7 (see 
Figure 33) with a bond length of 2.597 Å (see Table 1).  This bond length represents a strong 
hydrogen bond. Given that hydrogen bonds require a proton acceptor and donor to be present, 
oxygen 4 in this scenario acts as the acceptor to oxygen 7’s proton donor.  
Intramolecular (Donor-
Hydrogen···Acceptor) 
    









O7 O4 2.597(3) 
 
O7 H7A O4 48.7(15) 
H7A O4 3.084(19) 
     Table 2 – all of the intramolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angle from [Cu(ACV)2(H2O)3]•2(BF4). 
3.2.5. Scanning Electron Microscope Data 
 
Figure 34 – SEM data from [Cu(ACV)2(H2O)3]•2(BF4). 
This SEM data (Figure 34) shows what elements the crystal 1 compound was composed of. It was 
observed that organic elements, such as carbon, nitrogen, oxygen and fluorine which make up the 
acyclovir ligands and the BF4
- counter ion, were all present, in addition to copper which was the 
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metal centre of the compound. SEM instruments have a sensitivity limit which precludes the 
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3.2.6. 2 [Cu(ACV)2 (H2O)2(OH)2]•ACV + 2H2O 
 
Figure 35 – Crystal 2: [Cu(ACV)2 (H2O)2(OH)2]•ACV + 2H2O labelled. 
This copper centred molecule adopts an octahedral structure with a space group of 𝑃1 (triclinic). It 
has six total binding ligands, two aqua ligands, two hydroxyl ligands and two ACV ligands to the 
copper central atom. As demonstrated in Figure 23 (i), the metal is bonded to the ACV via N4 or N1 
as it is seen in this crystal (Figure 35). There is also one non-bound ACV molecule in the crystal lattice 
that also appears in the asymmetric unit, as well as several water solvent molecules. There are no 
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3.2.7. Bond Angles 
 
 
Figure 36 – angles of ligand-metal-ligand in the equatorial plane of [Cu(ACV)2 (H2O)2(OH)2]•ACV + 2H2O 
 




Figure 37 – angles from the equatorial atoms to the axial atoms of [Cu(ACV)2 (H2O)2(OH)2]•ACV + 2H2O. 
As seen in Figure 36 and 37, the binding ligands of this octahedral complex are two hydroxyl ligands 
(O8) and two ACV ligands (N1) in the equatorial plane and two aqua ligands (O9) in the axial plane. In 
the equatorial plane this forms a square planar geometry and has the following angles: (O8-Cu1-N1) 
86.85° and (N1-Cu1-O8) 93.15°; each of these angles are seen twice as there are two hydroxyl and 
ACV ligands (Figure 36). As for the angles in the axial plane, each angle is different (Figure 37): (a) 
(O9-Cu1-N1) 88.63°, (b) (O9-Cu1-N1) 91.37°, (a) (O9-Cu1-O8) 84.84°, (b) (O9-Cu1-O8) 95.16°.  
A ‘perfect’ octahedral complex should form 90° angles from each ligand to another. However, in the 
case of [Cu(ACV)2 (H2O)2(OH)2] none of the angles are at an exact 90° which could be explained by 
any weak force inflicted by solvent molecules in the structure. Another explanation is steric 
competition between ligands. The water molecules are rather small, while the ACV are much larger 
in comparison, which may lead to the ligand angles differing from 90°. 
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3.2.8. Bond Distance 
 
Figure 38 – bond distances from the central copper atom to each of the binding ligand atoms of [Cu(ACV)2 (H2-
O)2(OH)2]•ACV + 2H2O 
The bond distances vary, especially the distances from the copper atom to those in the axial plane: 
(Cu1-O9) 2.417 Å, compared to those in the equatorial plane: (Cu1-O8) 1.948 Å, (Cu1-N1) 2.055 Å. 
This difference is explained by the Jahn-Teller distortion effect. Here, the molecular geometry 
changes to become less symmetrical to remove orbital degeneracy, thereby lowering the overall 
energy of the complex. The Jahn-Teller distortion causes the axial ligands to elongate and the 
equatorial ligands to contract to achieve this, lowering the energy and improving stability. 
In addition, the smaller bond lengths (Cu1-O8) are the hydroxyl ligands as they are more 
electronegative than the aqua ligands, and are therefore more attracted to the copper centres than 
the aqua ligands. 
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Another factor to mention is that the ligands in the equatorial plane can be described as trans- as 
the same ligands are on opposite sides, facing each other [20]. In addition, the two ACV ligands have 
their tails in different directions which may also help to minimise energy. 
3.2.9. Unit Cell, Intermolecular and Intramolecular Bonding 
 
Figure 39 – a cell unit within a unit cell (axes shown) in the b* plane view of [Cu(ACV)2 (H2O)2(OH)2]•ACV + 2H2O. 
The asymmetric unit only fits half of the unit cell which is 𝑃1 (triclinic). However, some of the 
molecules fall on the outside of the axes. Whilst the two non-bonded ACV molecules fit within, half 
of all the bonded ACV ligands are on the outside along with one equatorial bonded water molecule 
and one axial bonded water molecule. While the non-bonded ACV molecules fill some of the void 
within the unit cell, there are still voids that are filled by three ethanol molecules and two water 
molecules. 
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Figure 40 – the intermolecular hydrogen bonding shown: O9-H···O4, N10-H···O9, N10-H···O3, N5-H···O4, N4-H···N7, O6A- 
H···O2, and O3-H···O6A (Note: hydrogen atoms not displayed). 
In a packed cell of crystal 2, there are seven unique intermolecular bonds with three types of 
hydrogen bonding: O-H···O, O-H···N, and N-H···N. The distances between each of these hydrogen 
bonds differed slightly: (O9-H···O4) 2.844 Å, (N10-H···O9) 3.009 Å, (N10-H···O3) 2.934 Å, (N5-H···O4) 
2.997 Å, (N4-H···N7) 2.757 Å, (O6A-H···O2) 2.848 Å, (O3-H···O6A) 2.701 Å (see Table 3).  All of these 
intermolecular bonds were in the range of 2.5-3.2 Å [21] which suggests that they are all moderate 
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Intermolecular(Donor-Hydrogen···Acceptor) 
     
 






3 Angle / °  
 
O9 O4 2.844(7) 
 
O9 H9B O4 168.4(2) 
 
H9B O4 1.869(5) 
 
N10 H10B O9 134.9(3) 
 
N10 O9 3.009(7) 
 
N10 H10A O3 173.9(4) 
 
H10B O9 2.34(4) 
 
N5 H5B O4 159.9(5) 
 
N10 O3 2.934(9) 
 
N4 H4 N7 167.9(6) 
 
H10A O3 2.078(7) 
 
O6A H6AA O2 48.5(11) 
 
N5 O4 2.997(5) 
 
O3 H3A O6A 155.8(9) 
 
H5B O4 2.175(3) 
     
 
N4 N7 2.757(6) 
     
 
H4 N7 1.91(5) 
     
 
O6A O2 2.85(2) 
     
 
H6AA O2 3.325(5) 
     
 
O3 O6A 2.70(2) 
     
 
H3A O6A 1.93(2) 
     Table 3 - all of the intermolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angles from [Cu(ACV)2 (H2O)2(OH)2]•ACV + 2H2O. 
 
Figure 41 – the intramolecular bonds shown, O8-H···O1 (Note: hydrogen atoms not displayed). 
Only one case of intramolecular hydrogen bonds occurred within the Cu 2 crystal, an O-H···O: (O8- 
H···O1) with a distance of 2.573 Å (see Table 4).  At this distance the hydrogen bond is on the 
boundary of moderate strength, verging on strong, and is an intramolecular interaction meaning a 
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considerable amount of energy would be needed to break this bond. The intramolecular bond occurs 
in the equatorial plane between one ACV ligand and one hydroxyl ligand. 
Intramolecular(Donor-Hydrogen···Acceptor) 
    









O8 O1 2.573(6) 
 
O8 H8A O1 166.4(2) 
H8A O1 1.66(4) 
     Table 4 – all of the intramolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angle from [Cu(ACV)2 (H2O)2(OH)2]•ACV + 2H2O. 
3.2.10. Scanning Electron Microscope Data 
 
Figure 42 – SEM data of [Cu(ACV)2 (H2O)2(OH)2]•ACV + 2H2O 
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This SEM data (Figure 42) illustrates what elements make up the crystal 2 compound. Organic 
elements such as carbon, nitrogen and oxygen, which make up the acyclovir ligands, are present. 
However, there is no fluorine shown, which confirms the absence of BF4
- counter ions. Copper was 
found, confirming the metal centre of the compound and silicon was also observed, which is likely 
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3.2.11. 3 [Cu(ACV)4H2O]•2(BF4) 
 
Figure 43 – Crystal 3: [Cu(ACV)4H2O]•2(BF4) labelled 
Crystal 3 shows a square pyramidal geometry with five total bonding ligands to the central metal 
which is copper (Cu2+). Four of the ligands are ACV molecules, each of which bond in the format seen 
in Figure 23(i) at N1, N6, N10, and N16, all in the equatorial plane. The remaining ligand is an aqua 
ligand which sits in the axial plane. Also observed in the single crystal is the tetrafluoroborate ions 
which, being anions, act as counter ions that balance the overall charge of the single crystal to a 
neutral charge. No solvent can be seen within the voids of the molecule and crystal structure, even 
though ethanol was found to be critical to the synthesis of this crystal. 
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3.2.12. Bond Angles 
 
Figure 44 –[Cu(ACV)4H2O]•2(BF4) bond angles in the equatorial plane, ligand-metal-ligand. 
 
Figure 45 – bond angles of [Cu(ACV)4H2O]•2(BF4)  in the equatorial plane, ACV-metal-aqua. 
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For a square pyramidal-shaped compound, the angles between ligands should be ≤90°. However, the 
angles in crystal 3 do not equate to this (Figure 44): (N1-Cu1-N6) 91.3(1)°, (N6-Cu1-N11) 88.15(2)°, 
(N11-Cu1-N16) 88.95(1)°, and (N16-Cu1-N1) 90.14(1)° in the equatorial plane. The axial plane also 
differs from the ‘perfect’ angle of ≤90° (Figure 45): (N1-Cu1-O13) 93.48(9)°, (N6-Cu1-O13) 97.73(1)°, 
(N11-Cu1-O13) 91.85(9)°, and (N16-Cu1-O13) 97.81(9)°. The ACV ligands (not fully shown in Figures 
44 and 45) have their tails orientated in different directions: N1 and N11 have their tails pointing up 
in the Z axis, while N6 and N16 have their tails pointing down in the Z axis. 
The distortion in bond angles is explained by how the counter ions, two tetrafluoroborate (not 
shown in Figures 44 and 45), fill the voids. This influences the position of the ACV ligand, and 
therefore, the bond angle which isn’t ‘perfect’. In addition to this, the tail positions could also 
influence the final bond angles, as they find the best position to minimise repulsion of the counter 
anions and the other ligand tail. 
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3.2.13. Bond Distances 
 
Figure 46 – the bond distances of the bonding ligands to the central metal atom of [Cu(ACV)4H2O]•2(BF4). 
All of the distances between the bonding ligand atoms and the metal centre differ, with some only 
by a small amount (Figure 46): (Cu1-N1) 2.077(2) Å, (Cu1-N6) 1.963(3) Å, (Cu1-N11) 2.073(2) Å, (Cu1-
N16) 1.952(3) Å, and (Cu1-O13) 2.266(2) Å. The equatorial atoms are all roughly similar, with the 
exception of the Cu1-O13 distance, measuring the largest; more than ~0.200 Å longer than any of 
the others. 
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3.2.14. Unit Cell, Intermolecular and Intramolecular Bonding. 
 
Figure 47 – a cell unit of a [Cu(ACV)4H2O]•2(BF4) crystals viewed through the a axis (cell axes are shown). 
The asymmetric unit of crystal 3 lies within a quarter of the unit cell which has a space group of    
P21/n (monoclinic). The formation of this crystal is in a specific order, with each Cu 3 molecule 
stacking asymmetrically. In the example of Figure 47, the O13 on one molecule points left, then the 
O13 on the next molecule to its side points to the right. This pattern continues to form the wider 
crystal pattern. 
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Figure 48 – intermolecular hydrogen bonding between N5-H···O2, O13-H···O10, O6-H···N4, N19-H···O3, N20-H···O8, N20-
H···O9, N14-H···O9, N9-H···O7 and O13-H···O6 (Note: hydrogen atoms not displayed). 
72 | P a g e  
 
 
Figure 49 – intermolecular hydrogen bonds between N10-H···O2, O2-H···O12, O5-H···N8, O9-H···O5, N15-H···O10 and 
O12-H···N18 (Note: hydrogen atoms not displayed). 
Within Cu 3 crystals there are fifteen unique intermolecular hydrogen bonds, displayed in both 
Figures 48 and 49. Each bond is either an O-H···O bond or an O-H···N bond, all with various bond 
distances: (N5-H···O2) 2.824 Å, (O13-H···O10) 2.852 Å, (N4-H···O6) 2.950 Å, (N19-H···O3) 2.796 Å, 
(N20-H···O8) 3.026 Å, (N20-H ···O9) 3.008 Å, (N14-H···O9) 2.847 Å, (N9-H···O7) 2.730 Å, (O13-H···O6) 
2.918 Å, (N10-H···O2) 3.014 Å, (O2-H···O12) 2.692 Å, (O5-H···N8) 2.877 Å, (O9-H···O5) 2.679 Å, (O10-
H···N15) 3.033 Å, and (O12-H···N18) 2.942 Å (see Table 5).  All these bonds are within the moderate 
bond strength for intermolecular hydrogen bonds (2.5-3.2 Å) [21] meaning they will have a 
considerable influence on formation of these crystals. 
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Intermolecular (Donor-Hydrogen···Acceptor) 
    






3 Angle / ° 
N5 O2 2.824(4) 
 
N5 H5A O2 158.4(17) 
H5A O2 2.006(2) 
 
O13 H13B O10 107.4(17) 
O13 O10 2.852(3) 
 
N4 H4A O6 163.9(2) 
H13B O10 2.48(2) 
 
N19 H19 O3 161.3(19) 
N4 O6 2.950(3) 
 
N20 H20B O8 84.1(17) 
H4A O6 2.114(2) 
 
N20 H20B O9 135.2(18) 
N19 O3 2.796(3) 
 
N14 H14 O9 154.7(17) 
H19 O3 1.968(2) 
 
N9 H9A O7 171.2(18) 
N20 O8 3.026(3) 
 
O13 H13A O6 123.7(16) 
H20B O8 2.991(17) 
 
N10 H10B O2 125.3(2) 
N20 O9 3.008(3) 
 
O2 H2 O12 161.6(19) 
H20B O9 2.336(2) 
 
O5 H5 N8 177(4) 
N14 O9 2.847(4) 
 
O9 H9 O5 169.8(19) 
H14 O9 2.046(2) 
 
N15 H15B O10 176(4) 
N9 O7 2.730(3) 
 
O12 H12 N18 167(5) 
H9A O7 1.877(2) 
     O13 O6 2.918(3) 
     H13A O6 2.359(2) 
     N10 O2 3.014(3) 
     H10B O2 2.433(2) 
     O2 O12 2.692(3) 
     H2 O12 1.901(2) 
     O5 N8 2.877(4) 
     H5 N8 2.10(5) 
     O9 O5 2.679(3) 
     H9 O5 1.868(2) 
     N15 O10 3.033(3) 
     H15B O10 2.19(4) 
     O12 N18 2.942(4) 
     H12 N18 2.27(5) 
     Table 5 – all of the intermolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angles from [Cu(ACV)4H2O]•2(BF4). 
 
74 | P a g e  
 
3.2.15. Scanning Electron Microscope Data 
 
Figure 50 – SEM data of [Cu(ACV)4H2O]•2(BF4) 
This SEM data (Figure 50) shows the elemental composition of the crystal 3 complex. It is observed 
that there are organic elements such as carbon, nitrogen, oxygen and fluorine, which made up the 
acyclovir ligands and the BF4
- counter ion, as well as copper which was the metal centre of the 
compound. As stated earlier, lighter atoms hydrogen and boron are beyond the detection 
capabilities of the instrument. There is also silicon identified in this spectrum, which is found within 
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3.2.16. 4 [Cu(ACV)2(H2O)2]•2BF4 
 
Figure 51 – Crystal 4: [Cu(ACV)2(H2O)2]•2BF4 labelled. Note: they symmetry-generated tetrafluoroborate anion is 
omitted. 
This copper-centred crystal compound is a monoclinic molecule (P21/n) which has an octahedral 
structure. There are two types of ligands coordinated to the copper atom centre: two ACV ligands, 
with two unique bonding sites, and two aqua ligands. The ACV ligands are coordinated to the metal 
centre as seen in Figure 23(ii), taking the locations around the equatorial position at O1 and N4. The 
aqua ligands take both the axial positions above and below the copper centre via symmetry. Two 
tetrafluoroborate anions were identified which act as counter ions (one grown by symmetry), 
leading to an overall balanced compound. 
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3.2.17. Bond Angles 
 
 
Figure 52 – bond angles between each of the atoms in the equatorial plane of [Cu(ACV)2(H2O)2]•2BF4 
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Figure 53– bond angles between the equatorial plane and the atom within the axial plane of [Cu(ACV)2(H2O)2]•2BF4. 
There are four bonding atoms in the equatorial plane, however, two are symmetry-equivalent 
(Figure 52): two (N4-Cu1-O1) 102.68° and (O1-Cu1-N4) 77.32°. Each of the equatorial atoms have 
different angles with the atoms in the axial plane (Figure 53) (O1-Cu1-O4)a 82.65°, (O1-Cu1-O4)b 
97.35°, (N4-Cu1-O4)a 91.47°, and (N4-Cu1-O4)b 88.53°. These angles in the axial plane are mirrored 
on the opposite side with the O4 atom seen below the equatorial atoms.  
The angles do not correspond to the ‘perfect’ angles sizes of an octahedral structure which is 90° 
between each atom and the neighbouring atom. Some of these angles are close to the 90° angle, 
while others are far from it. This particular crystal is bound to two bidentate ligands in the equatorial 
plane, each ligand having two bonding sites. The rigid structure of the ligands would mean that some 
of the bonding atoms would have to compromise the ‘perfect’ angle of 90° in order to bond. 
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3.2.18. Bond Distance 
 
 
Figure 54 – bond lengths between the copper centre and the bonding atoms of [Cu(ACV)2(H2O)2]•2BF4 
Though there are six bonding atoms from ligands to the metal centre, three are symmetry-
equivalent pairs (Figure 54): (O1-Cu1) 2.701 Å, (N4-Cu1) 2.002 Å, and (O4-Cu1) 1.956 Å. The 
distances of (O4-Cu1) and (N4-Cu1) only differ by ~0.050 Å, however (O1-Cu1) was an outlier despite 
being part of the same ligand as N4.  
Compounds with copper that have an octahedral geometry usually show a level of distortion caused 
by the Jahn-Teller effect. This crystal structure demonstrates this effect, wherein the bonding O1 
from the chelating ACV ligand is elongated to 2.701 Å. 
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3.2.19. Unit Cell, Intermolecular and Intramolecular Bonding 
 
Figure 55 – packing of [Cu(ACV)2(H2O)2]•2BF4 as seen from view a. Note: hydrogen atoms not displayed. 
Crystal 4’s asymmetric unit fills only a quarter of the unit cell which has a space group of P21/n 
(monoclinic). Two molecules of Cu 4 next to each other on either end of the axes with a central Cu 4 
molecule stack to form a crystal structure (Figure 55). This is replicated in another identical layer 
underneath the initial layer. 
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Figure 56 – the intermolecular hydrogen bonding between [Cu(ACV)2(H2O)2]•2BF4 molecules (Note: hydrogen atoms not 
displayed) 
There are three different intermolecular hydrogen bond types: O-H···O, O-H···N, and N-H···N. These 
are seen in four unique intermolecular bonds: (O4-H···O1) 2.714 Å, (O3-H···O4) 2.665 Å, (N1-H···O2) 
3.010 Å, and (N1-H···N2) 3.048 Å (see Table 6).. All of these bonds fall into the moderate 
intermolecular hydrogen bond strength region of 2.5-3.2 Å, meaning that these bonds would have a 
significant impact in the development of the crystal and a moderate amount of energy would be 
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Intermolecular (Donor-Hydrogen···Acceptor) 
    






3 Angle / ° 
O4 O1 2.714(3) 
 
O3 H3A O4 108.7(2) 
H4A O1 1.943(2) 
 
O4 H4A O1 148.8(18) 
O3 O4 2.665(4) 
 
N1 H1A N2 175.2(2) 
H3A O4 2.287(2) 
 
N1 H1B O2 102.8(2) 
N1 O2 3.010(4) 
     H1B O2 2.701(2) 
     N1 N2 3.048(4) 
     H1A N2 2.19(3) 
     Table 6 – all of the intermolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angles from [Cu(ACV)2(H2O)2]•2BF4. 
There were no intramolecular bonds that were observed in crystal 4. 
3.2.20. Scanning Electron Microscope Data 
 
Figure 57 – a SEM spectrum of [Cu(ACV)2(H2O)2]•2BF4 
This SEM data (Figure 57) indicates elements present in the crystal 4 compound. It is observed that 
there are organic elements such as carbon, nitrogen, oxygen and fluorine, which made up the 
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acyclovir ligands and the BF4
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3.2.21. 5 [Cu(ACV)2(BF4)2]•ACV + 2H2O 
 
Figure 58 – Crystal 5: [Cu(ACV)2(BF4)2]•ACV + 2H2O labelled. Note: hydrogen atoms not displayed. 
Crystal 5 is a square planar structured molecule which is a triclinic space group (𝑃1) (Figure 58). It 
has a copper metal centre bound to four ligands, however, there are only two unique ligands: ACV 
and BF4
- which are positioned in a trans formation with either side of the copper equator having one 
ACV ligand and one BF4
- ligand. The ACV ligands bond to the copper centre in the same position as 
seen in Figure 23(i) bonding to N1. There is one spectating ACV molecule that is not attached in any 
way to the metal centre or the other ligands. The overall charge of the crystal 5 molecule is neutral 
as the two BF4
- ions, which both bond to the Cu2+, balance the charge.  
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3.2.22. Bond Angles 
 
Figure 59 – bond angles between each of the bonding atoms in [Cu(ACV)2(BF4)2]•ACV + 2H2O. 
Being square planar, there are only four angles in total, and via symmetry, there are only two unique 
angles (Figure 59): (N1-Cu1-F2) 90.11° and (F2-Cu1-N1) 89.89°. Square planar molecules should have 
a 90° angle between bonding atoms for the ‘perfect’ molecule structure. Whilst the angles are not 
exactly 90° they are only out by ±0.11° and are within error. The size of the ligands which bond to 
the metal centre would cause the slight difference, but there is no distortion occurring. 
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3.2.23. Bond Distances 
 
Figure 60 – bond distances from the copper centre to the bonding ligand atoms of the [Cu(ACV)2(BF4)2]•ACV + 2H2O 
Although there are four bonding atoms to the metal centre, there are only two unique 
measurements (Figure 60): (Cu1-N1) 1.982 Å and (Cu1-F2) 1.956 Å. The similarities in these distances 
are very close thus demonstrating the highly-symmetrical nature of this structure. Even though the 
ligands alter the distances very slightly, crystal 5 can be likened to a ‘perfect’ square planar 
structure. 
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3.2.24. Unit Cell, Intermolecular and Intramolecular Bonding 
 
Figure 61 – a cell unit of [Cu(ACV)2(BF4)2]•ACV + 2H2O, viewed from the a plane. Note: hydrogen atoms not displayed. 
The asymmetric unit is 𝑃1 (triclinic). Some atoms from the bonding ACV and observing ACV grow 
outside of the cell unit axes (Figure 61), but largely fall within them. The crystal packing of crystal 5 is 
of one molecule layering another, with the secondary complex staggered off to one side. The 
spectating ACV sandwiches these stacked molecules. 
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Figure 62 – intermolecular hydrogen bonds in [Cu(ACV)2(BF4)2]•ACV + 2H2O are N4-H···N6, N5-H···O4, N10-H···N8, N10-
H···O6, and O6-H···N9. (Note: hydrogen atoms not displayed). 
There are five unique intermolecular hydrogen bonds consisting of N-H···N and O-H···N (Figure 62): 
(N4-H···N6) 2.850 Å, (N5-H···O4) 2.825 Å, (N10-H···N8) 2.983 Å, (N10-H···O6) 3.018 Å, and (O6-H···N9) 
2.787 Å (see Table 7). All of these hydrogen bonds fall into the moderate region of hydrogen bond 
strength, between 2.5-3.2 Å, which means that these bonds are significant in the forming of this 
crystal; a moderate amount of energy would be needed to break them. 
Intermolecular (Donor-Hydrogen···Acceptor) 
    






3 Angle / ° 
N4 N6 2.850(4) 
 
N4 H4 N6 172.6(16) 
H4 N6 1.995(3) 
 
N5 H5B O4 156.4(17) 
N5 O4 2.825(4) 
 
N10 H10A N8 160.4(3) 
H5B O4 2.015(3) 
 
N10 H10B O6 143(4) 
N10 N8 2.983(4) 
 
O6 H6 N9 47.9(2) 
H10A N8 2.155(3) 
     N10 O6 3.018(5) 
     H10B O6 2.39(5) 
     O6 N9 2.787(4) 
     H6 N9 3.269(2) 
     Table 7 – all of the intermolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angles from [Cu(ACV)2(BF4)2]•ACV + 2H2O 
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3.2.25. Scanning Electron Microscope Data 
 
Figure 63 – SEM data of [Cu(ACV)2(BF4)2]•ACV + 2H2O 
This SEM data (Figure 63) shows what elements made up the crystal 5 compound. There are the 
organic elements such as carbon, nitrogen, oxygen and fluorine, which made up the acyclovir ligands 
and the BF4
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3.3. Zinc Complexes 6 
3.3.1. 6 [Zn(ACV)4]•SiF6+ H2O 
 
Figure 64 – Crystal 6: [Zn(ACV)4]•SiF6+ H2O labelled. Note: hydrogen atoms not displayed. 
The only zinc containing crystal in this study’s selection is crystal 6. It has a triclinic,  𝑃1 space group 
and is tetrahedral molecule in nature. Bonding to the zinc metal centre are four ACV ligands, each 
bonding by N1, N6, N11, and N16. Each of the coordinating ACV nitrogen atoms bonds in the mode 
reported in Figure 23(i) with each of the tails alternating in orientation, never facing each other for 
geometric optimisation. The overall charge of the molecule is neutral because of a single counter 
anion, SiF6
2-, which balances the positively charged zinc atom. The counter ion is postulated to form 
from the breakdown of BF4
-, which then interacts with silica sourced from the glassware. 
90 | P a g e  
 
3.3.2. Bond Angles 
 
 
Figure 65 – the angles of each of the three surrounding atoms (N1, N6, N11) with each other in [Zn(ACV)4]•SiF6+ H2O. 
 
Figure 66 – the angles from each of the surrounding atoms (N1, N6, N11) to the remaining atom (N16) in 
[Zn(ACV)4]•SiF6+ H2O. 
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Tetrahedral structures have atoms surrounding the central metal atom. The three angles 
surrounding the zinc centre are (N1-Zn1-N6) 107.85(1)°, (N6-Zn1-N11) 115.07(1)°, and (N16-Zn1-N1) 
107.39(1)° (Figure 65). For a tetrahedral shaped structure, the ideal bond angle would be 109.5°, 
which none of these angles are. However, two angles in this compound are close to this ‘perfect’ 
measurement whilst one of the angles was vastly different with a measurement of 115.07°. The 
explanation could be that while the ligands would find a place of geometric stability, they may have 
to be further than ideal from each other, leading to this larger bond angle. 
As for the bond angles to the remaining atom, they differed to the ideal too (Figure 66): (N1-Zn1-
N16) 118.53(1)°, (N6-Zn1-N16) 102.39(1)°, and (N11-Zn1-N16) 105.94(1)°. As previously mentioned, 
the geometric optimisation of the ligands would try to minimise any energy caused by steric 
repulsion of the ligands which leads to these bond angles differing from the ideal measurements. 
3.3.3. Bond Distances 
 
Figure 67 – the bond lengths between the Zinc centre and the bonding ACV ligands in [Zn(ACV)4]•SiF6+ H2O. 
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In crystal 6, there are four unique bond lengths (Figure 67): (Zn1-N1) 1.987(3) Å, (Zn1-N6) 1.988(3) Å, 
(Zn1-N11) 2.008(2) Å, and (Zn1-N16) 2.009(2) Å. Whilst all of these bond lengths differ, they are very 
similar, all being with in a ~0.020 Å range. The slight difference is very close to the error margin, and 
may be caused by the ligand steric repulsion as previously explained. 
3.3.4. Unit Cell, Intermolecular and Intramolecular Bonding 
 
Figure 68 – cell unit of [Zn(ACV)4]•SiF6+ H2O, viewed through C*. Note: hydrogen atoms not displayed. 
The packing of this crystal involves considerable stacking with rows of complexes facing each other, 
in seemingly reverse mirror image.  
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Figure 69– the intermolecular hydrogen bonds between [Zn(ACV)4]•SiF6+ H2O molecules: N15-H···O10, N4-H···O12, N10-
H···N8, N10-H···O11, N20-H···O7, and O3-H···O4  (Note: hydrogen atoms not displayed). 
Between crystal 6 molecules there are six unique intermolecular hydrogen bonds consisting of O-
H···O, O-H···N, N-H···N, and N-H···O bonds (Figure 69): (N15-H···O10) 2.795 Å, (N4-H···O12) 2.804 Å, 
(N10-H···N8) 3.027 Å, (N10-H···O11) 2.834 Å, (N20-H···O7) 2.779 Å, and (O3-H···O4) 2.714 Å (see 
Table 8). Each of these bonds fall within the moderate strength region for hydrogen bonds, meaning 
that they have a significant influence on the formation of this crystal structure, and that it would 
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Intermolecular (Donor-Hydrogen···Acceptor) 
   




3 Angle / ° 
N15 O10 2.795(3) 
 
N15 H15A O10 120.4(19) 
H15A O10 2.26(2) 
 
N4 H4 O12 175.3(2) 
N4 O12 2.804(5) 
 
N10 H10A N8 151(2) 
H4 O12 1.945(4) 
 
N10 H10B O11 105.9(2) 
N10 N8 3.027(4) 
 
N20 H20A O7 140.3(19) 
H10A N8 2.246(3) 
 
O3 H3 O4 176.7(19) 
N10 O11 2.834(4) 
     H10B O11 2.475(2) 
     N20 O7 2.779(3) 
     H20A O7 2.063(19) 
     O3 O4 2.714(4) 
     H3 O4 1.896(2) 
     Table 8 – all of the intermolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angles from [Zn(ACV)4]•SiF6+ H2O 
3.3.5. Scanning Electron Microscope Data 
 
Figure 70 – the SEM data for [Zn(ACV)4]•SiF6+ H2O. 
This SEM data for crystal 6 (Figure 70) indicated the elements that make up the crystal. There are 
organic elements such as carbon, nitrogen, oxygen and fluorine, which make up the acyclovir ligands 
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and the SiF6
2- counter ion. Additionally, zinc was identified which was the metal centre of the 
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3.4. Silver Complexes 7-9 
3.4.1. 7 2[Ag2(ACV)3]•2SiF6+ 3H2O 
 
Figure 71 – Crystal 7: 2[Ag2(ACV)3]•2SiF6+ 3H2O labelled. Note: hydrogen atoms not displayed. 
Crystal 7 is a monoclinic crystal with a space group of P2/c which is comprised of sheets of 
complexes seen in Figure 71. The metal atom in this framework is silver, with a composition of three 
ACV ligands to two silver atoms. Metal coordination of the ACV differs in that a single, central ACV 
coordinates two metal centres, whereas the terminal ACV ligands coordinate silver atoms in a more 
traditional way, shown in Figure 23 (i) and (iii). The terminal ACV ligands only bond to one silver 
atom as seen in Figure 23 (i). There are two counter anions observed which are both SiF6
2- which 
counter the positively charged silver atoms leaving an overall neutrally charged dimeric complex. 
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3.4.2. Bond Angles 
 
Figure 72 – cropped image showing the bond angles from ligand-metal-ligand from the 2[Ag2(ACV)3]•2SiF6+ 3H2O 
complex. 
In total there are four unique bond angles involving the bonding of the ligand atom to the silver 
metal centre and the other bonding ligand atom (Figure 72). These bond angles are (N00R-Ag01-
N00G) 170.22(3)°, (N00T-Ag02-N00N) 168.98(3)°, (N00X-Ag03-N00Q) 168.36(4)°, and (N01B-Ag04-
N01I) 168.64(4)°; all of these bond angles are very similar with the largest deviation being 1.86°. The 
similarities of these angles show that they all follow a similar pattern of linear coordination. 
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3.4.3. Bond Distances 
 
Figure 73 – cropped image showing the bond distances from the bonding ligand atom to the central metal atom in 
2[Ag2(ACV)3]•2SiF6+ 3H2O. 
In an asymmetric cell of crystal 7 there are eight unique bond lengths (Figure 73): (Ag1-N00R) 
2.105(1) Å, (Ag1-N00G) 2.116(9) Å, (Ag2-N00T) 2.150(1) Å, (Ag2-N00N) 2.127(9) Å, (Ag3-N00Q) 
2.153(9) Å, (Ag3-N00X) 2.133(1) Å, (Ag4-N01I) 2.127(1) Å, and (Ag4-N01B) 2.119(1) Å. The sum of 
these bond lengths differs by up to 0.048 Å, which is within experimental error.  
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3.4.4. Unit Cell, Intermolecular and Intramolecular Bonding 
 
Figure 74 – a cell unit of 2[Ag2(ACV)3]•2SiF6+ 3H2O, viewed through B. 
The asymmetric unit of crystal 7 fits a quarter of the cell contents and has a space group of P2/c 
(monoclinic). The asymmetric unit consists of two complexes staggered relative to one another; 
these grow to form layers that overlap.  
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Figure 75 – intermolecular hydrogen bonds between molecules in 2[Ag2(ACV)3]•2SiF6+ 3H2O (Note: hydrogen atoms not 
displayed). 
 
Figure 76 – expanded view of the intermolecular hydrogen bonds between molecule: N00K-N02G and N01M-O008 
(Note: hydrogen atoms not displayed). 
There are two unique intermolecular hydrogen bonds made up of N-H···N and N-H···O (Figure 75 and 
Figure 76): (N02G-H···N00K) 2.953 Å and (N01M-H···O008) 2.847 Å(see Table 9). These hydrogen 
bond lengths are within the moderate bond length range and therefore are significant bonds in the 
formation of this crystal. It also means that a moderate amount of energy would be needed to break 
these bonds. 
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Intermolecular (Donor-Hydrogen···Acceptor) 
    









N02G N00K 2.95(1) 
 
N01M H01A O008 105.6(6) 
H02H N00K 2.094(9) 
 
N02G H02H N00K 176.4(7) 
N01M O008 2.85(1) 
     H01A O008 2.493(8) 
     Table 9 - all of the intermolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the Donor-
Hydrogen···Acceptor angles from 2[Ag2(ACV)3]•2SiF6+ 3H2O 
 
Figure 77 – intramolecular hydrogen bonds seen within 2[Ag2(ACV)3]•2SiF6+ 3H2O: N00L -H···O007 and N02Q -H···O00C 
(Note: hydrogen atoms not displayed). 
The two intramolecular hydrogen bonds are the same bond type, N-H···O (Figure 77). (N00L-
H···O007) 2.911 Å and (N02Q-H···O00C) 2.862 Å (see Table 10), both falling in the moderate region of 
hydrogen bond strength, meaning that they would both need moderate energy to break them. 
Intramolecular (Donor-Hydrogen···Acceptor) 
    









N02Q O00C 2.86(2) 
 
N02Q H02O O00C 116.5(9) 
H02O O00C 2.371(9) 
 
N00L H00A O007 164(7) 
N00L O007 2.91(1) 
     H00A O007 2.074(8) 
     Table 10 – all of the intramolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the 
Donor-Hydrogen···Acceptor angles from 2[Ag2(ACV)3]•2SiF6+ 3H2O 
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3.4.5. Scanning Electron Microscope Data 
 
Figure 78 – the SEM data for 2[Ag2(ACV)3]•2SiF6+ 3H2O 
This SEM data for crystal 7 (Figure 78) shows the elemental composition of the compound. There are 
organic elements such as carbon, nitrogen, oxygen and fluorine, which make up the acyclovir ligands 
and the SiF6
2- counter ion, as well as silver which was the metal of the compound’s framework. 
Silicon could be found in the counter ion as well as the SEM instrument platform. 
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3.4.6. 8 2[Ag(ACV)]•SiF6 + 2H2O 
 
Figure 79 – Crystal 8: 2[Ag(ACV)]•SiF6 + 2H2O labelled asymmetric unit. Note: some hydrogen atoms omitted. 
This monoclinic structure with a space group of P21 does not appear to have a typical structure, 
given that the ACV molecule bonds to a silver atom (Figure 79). The silver atoms bond to their 
individual ACV molecules in the fashion seen in Figure 23 (iii). Within one asymmetric unit of crystal 
8, there are two molecules of ACV with the bonding silver atoms. Also observed is a SiF6
2- molecule 
which acts as a counter ion leading to an overall charge of crystal 8 to be neutral. 
3.4.7. Bond Angles 
In each molecule observed in crystal 8, both silver atoms had the angles of interest measured: (N1-
Ag1-N4) 162.06(2)° and (N6-Ag2-N9) 155.78(1)° differing by only 6.28°. The complex’s structure is a 
polymer as there is a continuous chain of each respective monomer unit (the monomers seen in 
Figure 80). Crystal 8 is a linear polymer and does not have an ideal bonding angle. However, the 
angles explored are similar which could indicate that they follow a similar pattern.  
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3.4.8. Bond Distances 
Both silver atoms and the bonding atom were measured for length: (Ag1-N1) 2.192(3) Å and (Ag2-
N6) 2.207(3) Å. As previously stated, the crystal complex is a linear polymer consisting of repeating 
units with identical bond lengths. Both lengths are similar, differing by 0.015 Å. The similarities show 
that this is a well distributed molecule with little distortion.  
3.4.9. Unit Cell, Intermolecular and Intramolecular Bonding 
 
Figure 80 – a cell unit of 2[Ag(ACV)]•SiF6 + 2H2O, viewed from a. Note: hydrogen atoms not displayed. 
The asymmetric unit fits a quarter of the cell of this monoclinic crystal (P21), packing these 
monomers units together. Two of these units are in the centre of the cell axes, stacked on top of 
each other and slightly staggered (Figure 80). One monomer unit of crystal 8 polymer is on either 
side of the central asymmetric unit, each facing a different way to the other. Some atoms of the cell 
unit do fall on the outside of the axes, however, a majority are within. 
As previously discussed, crystal 8 is a polymer formed from many of the individual monomer units. 
Due to the nature of this polymer, there is no intermolecular bonding that occurs. 
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Figure 81 – Both intramolecular Hydrogen Bonds coordination bonds between 2[Ag(ACV)]•SiF6 + 2H2O molecules (Note: 
hydrogen atoms not displayed). 
There are two unique intramolecular hydrogen bonds between the crystal 8 polymer consisting of         
N-H···O bonds (Figure 81): (N2-H···O1) 2.825 Å, and (N7-H···O4) 2.901 Å(see Table 11). As one 
monomer of crystal 8 has the silver atom in the position described in Figure 23 (iii), when it forms 
into a polymer the silver atom of an adjoining monomer will bond in the format seen in Figure 23 (i). 
These bonds are within the moderate region of hydrogen bond strength which means they are 








    









N7 O4 2.90(5) 
 
N2 H2A O1 160(19) 
H7A O4 2.06(3) 
 
N7 H7A O4 154(2) 
N2 O1 2.82(4) 
     H2A O1 2.00(2) 
     Table 11 – all of the intramolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the 
Donor-Hydrogen···Acceptor angles from 2[Ag(ACV)]•SiF6 + 2H2O 
The crystal data from this complex suggested an intramolecular bond between the silver atoms and 
the oxygen atom in the ACV tail (Ag1···O2and Ag2··· O5). However, the data around this bond isn’t 
strongly reassuring to conclusively accept this bond, as well as the chemical impossibility of these 
bonds as the oxygen atoms are not pronated. 
3.4.10. Scanning Electron Microscope Data 
 
Figure 82 – the SEM data for 2[Ag(ACV)]•SiF6 + 2H2O. 
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This SEM data for crystal 8 (Figure 82) shows what elements are present within the crystal. There are 
organic elements such as carbon, nitrogen, oxygen and fluorine, which make up the acyclovir ligands 
and the SiF6
2- counter ion, as well as silver which is the metal within this complex. Silicon is also 






108 | P a g e  
 
3.4.11. 9 2[Ag(ACV)2]•SiF6+ 2H2O 
 
Figure 83 –Crystal 9: 2[Ag(ACV)2]•SiF6+ 2H2O labelled  
Crystal 9 is a triclinic compound with a space group of 𝑃1 that forms in sheets of the single 
molecules that make up the asymmetric unit (Figure 83). One asymmetric unit is made up of two 
molecules of a silver centred molecule with two ACV ligands to either side of it. These ACV ligands 
bond to the silver in the same way as seen in Figure 23 (i). In this example, the bonding atoms are 
N1, N6, N12, and N16. The two complexes are aligned in a staggered way. The observed counter ion 
was a SiF6
2- anion which charge-balances the complex to achieve overall neutrality. 
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3.4.12. Bond Angles 
 
Figure 84 – cropped image comparing the bond angles measured from the bonded atom to the silver to the other 
bonded atom in 2[Ag(ACV)2]•SiF6+ 2H2O. 
The bond angles are taken from the two ACV nitrogen atoms of either ligand, through the silver 
atom (Figure 84): (N1-Ag1-N6) 176.68(2)° and (N12-Ag2-N16) 176.99(2)°. The two angles are very 
similar, only differing by 0.31°, which is within experimental error. 
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3.4.13. Bond Distances 
 
Figure 85 – cropped image comparing bond distances measured from the silver atom to the bonding atoms in 
2[Ag(ACV)2]•SiF6+ 2H2O. 
There are four unique lengths between the silver atom and the bonding atom from the ACV ligand 
(Figure 85): (Ag1-N1) 2.100(5) Å, (Ag1-N6) 2.099(5) Å, (Ag2-N12) 2.090(5) Å, and (Ag2-N16) 2.091(5) 
Å. All the bond lengths are consistent with each other differing by 0.10 Å, which is within 
experimental error. 
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3.4.14. Unit Cell, Intermolecular and Intramolecular Bonding 
 
Figure 86 – unit cell of 2[Ag(ACV)2]•SiF6+ 2H2O, viewed through a. Note: hydrogen atoms not displayed. 
This 𝑃1, triclinic asymmetric unit takes up half of the cell unit (Figure 86) with the packing of crystal 
9 consisting of two silver-ACV complexes staggered relative to one another, with each complex 
having the same composition.  
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Figure 87 – the intermolecular hydrogen bonds between 2[Ag(ACV)2]•SiF6+ 2H2O molecules: N8-H···-N9, O7-H···O12, N4-
H···O7,  N5-H···O7, N20-H···O3, N20-H···N3, and N5-H···N18.   (Note: hydrogen atoms not displayed). 
Intermolecular hydrogen bonding between crystal 9 molecules consists of seven unique bonds made 
up of N-H···N, O-H···O, N-H···O, and O-H···N (Figure 87): (N8- H···N9) 3.054 Å, (O7-H···O12) 2.802 Å, 
(N5-H···O7) 2.993 Å, (N4-H···O7) 2.793 Å, (N20-H···O3) 3.006 Å, (N20-H···N3) 3.018 Å, and (N5-
H···N18) 3.056 Å (see Table 12). These bond lengths all fall within the moderate region of hydrogen 
bond strength, meaning they are all significant in the formation of the crystal 9 complex and would 
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Intermolecular (Donor-Hydrogen···Acceptor) 
    









N8 N9 3.054(7) 
 
N8 H8A N9 172.4(4) 
H8A N9 2.2(5) 
 
N4 H4 O7 159.1(5) 
O7 O12 2.80(1) 
 
N5 H5B O7 145(4) 
H7C O12 2.03(10) 
 
O7 H7C O12 157.2(5) 
N5 O7 2.99(1) 
 
N20 H20A N3 171.8(4) 
H5B O7 2.247(7) 
 
N5 H5A N18 178.6(7) 
N4 O7 2.793(9) 
 
N20 H20B O3 146.1(4) 
H4 O7 1.973(6) 
     N20 N3 3.018(7) 
     H20A N3 2.164(5) 
     N5 N18 3.056(8) 
     H5A N18 2.196(5) 
     N20 O3 3.006(9) 
     H20B O3 2.254(7) 
     Table 12 – all of the intermolecular hydrogen bond lengths from Donor to Acceptor, hydrogen to Acceptor and the 
Donor-Hydrogen···Acceptor angles from 2[Ag(ACV)2]•SiF6+ 2H2O 
In crystal 9, there are no observed intramolecular hydrogen bonds between molecules.  
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3.4.15. Scanning Electron Microscope Data 
 
Figure 88 – the SEM data for 2[Ag(ACV)2]•SiF6+ 2H2O. 
This SEM data for crystal 9 (Figure 88) indicates what elements are within the crystal. There are 
organic elements such as carbon, nitrogen, oxygen and fluorine, which made up the acyclovir ligands 
and the SiF6
2- counter ion, as well as silver which was the metal used in the synthesis of this 
compound. Silicon was also identified which could be found in the counter ion as well as the SEM 
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4.1. Conclusion  
In this study, the focus was synthesising new crystalline forms of metal-ACV complexes, in order to 
characterise as many polymorphs as possible, and to analyse the metal-ligand bonding. In addition, 
the use of ACV as the ligand allowed for the scope of the study to incorporate the synthesis of 
potential antiviral medication and chemotherapeutic drugs which are highly sought after in 
medicine. Although the use of metal-ACV complexes have been the focus of other studies, only a 
few selected metals and a limited range of microbials and viruses had been examined. Furthermore, 
this study, as well as other studies, notes the insolubility of ACV in aqueous mediums and only 
partial solubility in certain organic solvents, such as methanol and ethanol. 
During this study, several crystallisations successfully led to the synthesis of new complexes with 
metal tetrafluoroborate salts and ACV ligands using different solvent mixtures and a variation of 
crystallisation methods. The process of characterising these different crystal structures involved 
powder X-ray diffraction (PXRD), infrared (IR) spectroscopy, and scanning electron microscope 
energy dispersive X-ray (SEM/EDX) analysis. Each of the three transition metal salts studied formed 
at least one unique crystal structure. 
The largest family of new crystal structures discovered were copper based complexes, with five 
distinctive crystals observed. These different crystal types were found using different ratios of metal 
to ligand as well as two different types of alcohol solvent: methanol and ethanol. The solubility of 
ACV in these solvents was similar to that described in existing literature. Nevertheless, when 
dissolved with the metal salt, the solubility of ACV increased; this was observed in all the 
crystallisations. Each copper complex took the geometric form of one of three coordination 
geometries: octahedral, square pyramidal, or square planar. Each allowed for unique bonding 
arrangements to occur between metal and ligand. 
The first three copper crystals were either square pyramidal (crystals 1 and 3) or octahedral (crystal 
2) and all bonded via N4 of the purine ring (see ‘Results and Discussion’ Figure 22 and 23 (i)), a 
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common bonding point for ACV to a metal in both this study and others in existing literature. 
However, in crystal 4 the ACV ligands bonded through two sites as bidentate ligands at N4 and via 
the carbonyl group on the purine ring, O1 (see ‘Results and Discussion’ Figure 23 (ii)). This is rarely 
observed in ACV ligands, prompting discussion in the ‘Literature Analysis’ of ACV’s pseudo bidentate 
nature. The moderate strength of observed hydrogen bonding from O1 to the copper centre ensures 
that crystal 4 adopts an octahedral geometry.  
Crystal 5, the final copper centred crystal, is the only square planar crystal observed in this study to 
be bonded with its counter ion, BF4
-. This unique bond is through one of the fluoride atoms directly 
to the copper centre. No evidence of a crystal of this kind, where both ACV and tetrafluoroborate 
ligands attached to the copper centre, could be found within the existing literature. 
The remaining four crystals are comprised of one zinc-based crystal, and three silver-based crystals. 
The only zinc crystal observed in this study is also the only structure with tetrahedral geometry, 
bonded to four ACV ligands, all by the N4 atom of the ACV molecule (see ‘Results and Discussion’ 
Figure 23 (i)). Crystals 7 and 9 were formed in a linear geometric shape, with both crystals containing 
one silver atom bound to two ACV ligands. Crystal 7 has one ACV ligand bonded by the N4 position, 
which is commonly seen; the other ACV ligand coordinates via the N3 position. In crystal 9, ACV only 
bonds through N4. Both of these crystals are unique because they form a polymeric chain of 
repeating units within their solid-state structures. Although polymeric chains have been discussed in 
literature, [16], it is seldom mentioned that they replicate units outwards from the metal centre. 
The final silver crystal, crystal 8, contains two symmetrical monomers formed of one ACV bonding to 
one silver atom via the N3 position. Crystal 8 is a polymer that forms a continuous chain from each 
separate monomer, bonding via the silver atom in the N3 position of the ACV ligands to another 
monomer’s ACV ligand in the N4 position (see ‘Results and Discussion’ Figure 23 (i) and (iii)). Also 
observed was Ag···O interactions, however, it was a chemical impossibility which did not have strong 
data to support it. 
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PXRD data of samples containing their individual polymorphs was collected; however, there were 
several samples that were either of low crystallinity, or a combination of other crystal polymorphs. 
Crystals 3 and 4 all matched when the measured PXRD data was compared to that of the predicted 
PXRD data. All the other crystals’ data was similar to their predicted data pattern, which was to be 
expected as they contained a quantity of the corresponding crystal polymorph. Discrepancies 
between predicted and observed data were as a consequence of polymorphs that had either not 
been isolated or accounted for.  
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4.2. Future Work 
Furthering this study into the polymorphs of biologically relevant metals with ACV, a wider range of 
solvents will need to be evaluated, as previously discussed, due to some polymorphic structures 
being dependent on the medium they are dissolved and react in. A range of organic and inorganic 
solvents, such as water, hexane and toluene, would be a few to suggest for future study. Moreover, 
mixtures of solvents, such as a water/methanol or water/ethanol solution may also be worthy of 
further investigation. Finding strategies to increase the yield of each product using different solvents 
is also required, as this is necessary for undertaking the analytical techniques for characterisation. 
Evaluating a broader range of metal tetrafluoroborates is necessary for further studies to ensure 
that ACV can retain its function as an antiviral and that the metal does not cause any adverse effects 
to the patient through in vitro and animal testing. For example, metals already found in existing 
medications and biologically relevant metals. Metals such as iron (Fe(BF4)2), and magnesium 
(Mg(BF4)2) could be used as they each have specific in vivo roles. 
Different crystallisation methods could also be assessed as these are another way to synthesise new 
potential polymorphs. Two techniques which could be considered are vapour diffusion and 
sublimation. These techniques are a suitable expansion of this study, as the solvents already in use, 
such as methanol and ethanol, have low boiling points and are therefore well suited to vapour-based 
crystallisation methods. 
Mixtures observed in the PXRD data, particularly for the zinc compound for which this study only 
isolated one polymorph, requires further study. These mixtures will need to be separated in order 
for the single crystals to be isolated and analysed by single crystal XRD. 
Other analytical techniques may also be applied, such as thermal analysis. Using methods such as 
thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) would give insight into 
the solvents within each crystal’s structure and the identity of bound solvent to the metal centre. As 
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well as knowledge of the solvents, polymorphs can switch under different temperatures, and would 
be identifiable on a TGA spectrum.  
Further work into bioactivity and antiviral studies of the crystals featured in this thesis will have to 
be completed prior to practical application. As previous studies have shown (see in Literature 
Analysis), metal-ACV complexes are active against fungi microbials, have an impact on viruses for up 
to 3 consecutive days, and have been used effectively against adenocarcinoma cell (metal 
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Appendix B 
Cu 1 Crystal Data 
Identification code  acvcu_002 
Empirical formula  C8 H14.69 B Cu0.50 F4 N5 O5.50 
Formula weight  387.51 
Temperature  99.99(10) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 1 21/n 1 
Unit cell dimensions a = 9.4165(3) Å        α= 90°. 
  b = 33.5821(9) Å      β= 102.693(3)° 
  c = 9.5634(3) Å        γ = 90° 
Volume 2950.29(16) Å3 
Z 8 
Density (calculated) 1.745 Mg/m3 
Absorption coefficient 2.179 mm-1 
F(000) 1577 
Theta range for data 
collection 
4.920 to 61.703°. 
Index ranges -10<=h<=7, -38<=k<=38, -10<=l<=10 
Reflections collected 15245 
Independent reflections 4512 [R(int) = 0.0353] 
Completeness to theta = 
61.703° 
98.30% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.94070 
Refinement method Full-matrix least-squares on F2 
Data / restraints / 
parameters 
4512 / 5 / 475 
Goodness-of-fit on F2 1.041 
Final R indices [I>2sigma(I)] R1 = 0.0401, wR2 = 0.0993 
R indices (all data) R1 = 0.0517, wR2 = 0.1059 
Extinction coefficient n/a 
Largest diff. peak and hole 0.547 and -0.443 e.Å-3 
Table 13 – crystal data obtained from CIF data for Cu 1. 
Cu 2 Crystal Data 
Identification code  acv_cu_1to1 
Empirical formula  
C10.67 H21.41 Cu0.33 N6.67 
O8.71 
Formula weight  403.58 
Temperature  100.00(10) K 
Wavelength  1.54184 Å 
Crystal system  Triclinic 
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Space group  P -1 
Unit cell dimensions a = 7.3965(4) Å        α= 69.836(9)°. 
  b = 12.4980(12) Å   β= 87.977(6)°. 
  c = 15.5796(14) Å    γ = 87.476(6)°. 
Volume 1350.3(2) Å3 
Z 3 
Density (calculated) 1.489 Mg/m3 
Absorption coefficient 1.466 mm-1 
F(000) 634 
Theta range for data 
collection 
3.770 to 72.539°. 
Index ranges -9<=h<=6, -15<=k<=15, -19<=l<=17 
Reflections collected 9162 
Independent reflections 5152 [R(int) = 0.0446] 
Completeness to theta = 
67.684° 
99.60% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.87367 
Refinement method Full-matrix least-squares on F2 
Data / restraints / 
parameters 
5152 / 5 / 354 
Goodness-of-fit on F2 1.252 
Final R indices [I>2sigma(I)] R1 = 0.1077, wR2 = 0.3005 
R indices (all data) R1 = 0.1302, wR2 = 0.3289 
Extinction coefficient n/a 
Largest diff. peak and hole 1.835 and -0.858 e.Å-3 
Table 14 – crystal data obtained from CIF data for Cu 2. 
Cu 3 Crystal Data 
Identification code  acvcu_004 
Empirical formula  C32 H45 B2 Cu F8 N20 O13 
Formula weight  1155.04 
Temperature  291.45(10) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 1 21/c 1 
Unit cell dimensions a = 14.1928(8) Å      α= 90°. 
  b = 15.3243(7) Å      β= 103.552(5)° 
  c = 20.7830(9) Å       γ = 90°. 
Volume 4394.3(4) Å3 
Z 4 
Density (calculated) 1.746 Mg/m3 
Absorption coefficient 1.807 mm-1 
F(000) 2368 
Theta range for data 
collection 
3.620 to 70.298°. 
Index ranges -17<=h<=16, -16<=k<=18, -18<=l<=25 
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Reflections collected 17786 
Independent reflections 8113 [R(int) = 0.0459] 
Completeness to theta = 
67.684° 
99.00% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.84000 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8113 / 0 / 712 
Goodness-of-fit on F2 1.013 
Final R indices [I>2sigma(I)] R1 = 0.0466, wR2 = 0.1049 
R indices (all data) R1 = 0.0791, wR2 = 0.1207 
Extinction coefficient n/a 
Largest diff. peak and hole 0.816 and -0.528 e.Å-3 
Table 15 – crystal data obtained from CIF data for Cu 3. 
Cu 4 Crystal Data 
Identification code  cu_acetone 
Empirical formula  C8 H13 B Cu0.50 F4 N5 O4 
Formula weight  361.81 
Temperature  300.00(15) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 1 21/n 1 
Unit cell dimensions a = 4.9311(3) Å      α= 90°. 
  b = 14.2453(6) Å    β= 93.914(4)°. 
  c = 18.9826(8) Å    γ = 90° 
Volume 1330.32(11) Å3 
Z 4 
Density (calculated) 1.806 Mg/m3 
Absorption coefficient 2.278 mm-1 
F(000) 734 
Theta range for data 
collection 
3.883 to 61.552°. 
Index ranges -5<=h<=3, -15<=k<=7, -16<=l<=21 
Reflections collected 3799 
Independent reflections 2035 [R(int) = 0.0270] 
Completeness to theta = 
61.552° 
98.10% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.91685 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2035 / 0 / 215 
Goodness-of-fit on F2 1.074 
Final R indices [I>2sigma(I)] R1 = 0.0408, wR2 = 0.1052 
R indices (all data) R1 = 0.0571, wR2 = 0.1142 
Extinction coefficient n/a 
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Largest diff. peak and hole 0.489 and -0.424 e.Å-3 
Table 16 – crystal data obtained from CIF data for Cu 4. 
Cu 5 Crystal Data 
Identification code  cuacv4 
Empirical formula  C16 H24 B Cu0.50 F4 N10 O8.00 
Formula weight  603.39 
Temperature  263(50) K 
Wavelength  1.54184 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 5.0065(3) Å       α= 106.683(4)°. 
  b = 13.5389(6) Å       β= 91.482(4)°. 
  c = 18.2983(8) Å       γ = 94.832(4)° 
Volume 1182.25(11) Å3 
Z 2 
Density (calculated) 1.695 Mg/m3 
Absorption coefficient 1.758 mm-1 
F(000) 619 
Theta range for data 
collection 
3.616 to 70.126°. 
Index ranges -5<=h<=6, -16<=k<=15, -22<=l<=21 
Reflections collected 7599 
Independent reflections 4335 [R(int) = 0.0343] 
Completeness to theta = 
67.684° 
99.20% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.73562 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4335 / 0 / 389 
Goodness-of-fit on F2 1.039 
Final R indices [I>2sigma(I)] R1 = 0.0573, wR2 = 0.1590 
R indices (all data) R1 = 0.0638, wR2 = 0.1692 
Extinction coefficient n/a 
Largest diff. peak and hole 0.801 and -0.761 e.Å-3 
Table 17 – crystal data obtained from CIF data for Cu 5. 
Zn 1 Crystal Data 
Identification code  acvzn_001 
Empirical formula  C34 H54 F6 N20 O16 Si Zn 
Formula weight  1206.43 
Temperature  149.99(10) K 
Wavelength  1.54184 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 13.1171(2) Å   α= 94.6280(10)° 
132 | P a g e  
 
  b = 13.3905(2) Å   β= 95.3660(10)°. 
  c = 14.8131(2) Å   γ = 103.6360(10)° 
Volume 2503.19(6) Å3 
Z 2 
Density (calculated) 1.601 Mg/m3 
Absorption coefficient 1.891 mm-1 
F(000) 1248 
Theta range for data 
collection 




Reflections collected 37222 
Independent reflections 9745 [R(int) = 0.0349] 
Completeness to theta = 
67.684° 
99.90% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.83757 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9745 / 0 / 725 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0531, wR2 = 0.1393 
R indices (all data) R1 = 0.0605, wR2 = 0.1449 
Extinction coefficient n/a 
Largest diff. peak and hole 1.412 and -0.714 e.Å-3 
Table 18 – crystal data obtained from CIF data for Zn 1. 
Ag 1 Crystal Data 
Identification code  acvag_001 
Empirical formula  
C40 H60 Ag4 B0.25 F13 N49 O14 P2 
Si0.25 
Formula weight  2201.51 
Temperature  150.00(10) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 1 2/c 1 
Unit cell dimensions a = 10.6064(4) Å      α= 90°. 
  b = 25.5910(11) Å    β= 96.192(4)° 
  c = 27.2880(12) Å    γ = 90°. 
Volume 7363.5(5) Å3 
Z 4 
Density (calculated) 1.986 Mg/m3 
Absorption coefficient 10.004 mm-1 
F(000) 4379 
Theta range for data collection 3.454 to 61.720°. 
Index ranges -12<=h<=11, -28<=k<=13, -29<=l<=31 
Reflections collected 21889 
Independent reflections 11243 [R(int) = 0.0320] 
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Completeness to theta = 
61.720° 
97.80% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.79986 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11243 / 0 / 493 
Goodness-of-fit on F2 1.037 
Final R indices [I>2sigma(I)] R1 = 0.1079, wR2 = 0.2940 
R indices (all data) R1 = 0.1564, wR2 = 0.3401 
Extinction coefficient n/a 
Largest diff. peak and hole 4.017 and -1.463 e.Å-3 
Table 19 – crystal data obtained from CIF data for Ag 1. 
Ag 2 Crystal Data 
Identification code  acvag_002 
Empirical formula  C15 H0.50 Ag F4 N6 O3 Si0.50 
Formula weight  521.44 
Temperature  100.00(10) K 
Wavelength  1.54184 Å 
Crystal system  Monoclinic 
Space group  P 1 21 1 
Unit cell dimensions a = 7.0464(2) Å         α= 90°. 
  b = 25.5833(8) Å       β= 112.646(4)° 
  c = 7.4217(2) Å          γ = 90° 
Volume 1234.76(7) Å3 
Z 2 
Density (calculated) 1.402 Mg/m3 
Absorption coefficient 7.292 mm-1 
F(000) 503 
Theta range for data 
collection 
6.462 to 66.319°. 
Index ranges -8<=h<=8, -30<=k<=30, -8<=l<=8 
Reflections collected 20405 
Independent reflections 4274 [R(int) = 0.0665] 
Completeness to theta = 
66.319° 
99.20% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.76044 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4274 / 1 / 377 
Goodness-of-fit on F2 1.727 
Final R indices [I>2sigma(I)] R1 = 0.1546, wR2 = 0.3459 
R indices (all data) R1 = 0.1550, wR2 = 0.3466 
Absolute structure parameter 0.178(9) 
Extinction coefficient n/a 
Largest diff. peak and hole 19.922 and -2.885 e.Å-3 
Table 20 – crystal data obtained from CIF data for Ag 2. 
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Ag 3 Crystal Data 
Identification code  acvag2to1 
Empirical formula  C32 H49 Ag2 F6 N20 O15 Si 
Formula weight  1311.74 
Temperature  291.45(10) K 
Wavelength  1.54184 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 10.1680(3) Å     α= 97.841(2)°. 
  b = 14.9186(5) Å     β= 97.279(2)°. 
  c = 16.6814(5) Å    γ = 108.993(3)° 
Volume 2330.43(13) Å3 
Z 2 
Density (calculated) 1.869 Mg/m3 
Absorption coefficient 8.006 mm-1 
F(000) 1326 
Theta range for data 
collection 




Reflections collected 16243 
Independent reflections 8625 [R(int) = 0.0346] 
Completeness to theta = 
67.684° 
99.50% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.51167 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8625 / 3 / 706 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.0685, wR2 = 0.1830 
R indices (all data) R1 = 0.0746, wR2 = 0.1908 
Extinction coefficient n/a 
Largest diff. peak and hole 1.628 and -1.505 e.Å-3 










Bond Lengths (Å)   Bond Angles (°)   
Cu(1)-O(8)  1.9772 O(8)-Cu(1)-O(11) 89.469 
Cu(1)-O(11)  2.2182 O(8)-Cu(1)-N(6) 179.3911 
Cu(1)-O(7)  1.9552 O(8)-Cu(1)-N(5) 87.331 
Cu(1)-N(6)  2.0143 O(7)-Cu(1)-O(8) 87.219 
Cu(1)-N(5)  1.9893 O(7)-Cu(1)-O(11) 108.171 
F(8)-B(2)  1.3804 O(7)-Cu(1)-N(6) 92.471 
F(6)-B(2)  1.4064 O(7)-Cu(1)-N(5) 160.4011 
F(5)-B(2)  1.3824 N(6)-Cu(1)-O(11) 90.151 
F(7)-B(2)  1.3965 N(5)-Cu(1)-O(11) 90.591 
O(4)-C(13)  1.2474 N(5)-Cu(1)-N(6) 93.141 
O(5)-C(14)  1.4134 C(14)-O(5)-C(15) 113.52 
O(5)-C(15)  1.4454 Cu(1)-O(8)-H(8A) 110.4 
O(1)-C(5)  1.2304 Cu(1)-O(8)-H(8B) 110 
F(4)-B(1)  1.3855 H(8A)-O(8)-H(8B) 104 
F(1)-B(1)  1.3685 C(8)-O(3)-H(3) 109.5 
O(8)-H(8A)  0.8606 C(16)-O(6)-H(6) 109.5 
O(8)-H(8B)  0.8587 Cu(1)-O(11)-H(11A) 111.3 
F(3)-B(1)  1.3895 Cu(1)-O(11)-H(11B) 111 
O(3)-H(3)  0.82 H(11A)-O(11)-H(11B) 102.8 
O(3)-C(8)  1.4294 Cu(1)-O(7)-H(7A) 110.2 
O(6)-H(6)  0.82 Cu(1)-O(7)-H(7B) 110.7 
O(6)-C(16)  1.4384 H(7A)-O(7)-H(7B) 103.5 
O(11)-H(11A)  0.8842 C(13)-N(9)-H(9) 116.9 
O(11)-H(11B)  0.8838 C(12)-N(9)-H(9) 116.9 
O(7)-H(7A)  0.8638 C(12)-N(9)-C(13) 126.23 
O(7)-H(7B)  0.8663 C(10)-N(6)-Cu(1) 137.22 
F(2)-B(1)  1.4065 C(9)-N(6)-Cu(1) 118.42 
N(9)-H(9)  0.86 C(9)-N(6)-C(10) 104.43 
N(9)-C(13)  1.3844 C(1)-N(5)-Cu(1) 134.22 
N(9)-C(12)  1.3754 C(1)-N(5)-C(2) 105.32 
N(6)-C(10)  1.4064 C(2)-N(5)-Cu(1) 119.32 
N(6)-C(9)  1.3134 C(11)-N(7)-C(14) 125.73 
N(5)-C(1)  1.3144 C(9)-N(7)-C(11) 106.93 
N(5)-C(2)  1.3844 C(9)-N(7)-C(14) 127.43 
N(7)-C(11)  1.3754 H(10C)-O(10)-H(10D) 104.6 
N(7)-C(14)  1.4574 C(4)-N(2)-C(3) 112.33 
N(7)-C(9)  1.3564 C(3)-N(4)-C(6) 127.23 
O(10)-H(10C)  0.8508 C(1)-N(4)-C(3) 106.72 
O(10)-H(10D)  0.8496 C(1)-N(4)-C(6) 126.03 
N(2)-C(3)  1.3614 C(12)-N(8)-C(11) 112.13 
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N(2)-C(4)  1.3204 C(5)-N(3)-H(3A) 117.2 
N(4)-C(3)  1.3754 C(4)-N(3)-H(3A) 117.2 
N(4)-C(1)  1.3654 C(4)-N(3)-C(5) 125.53 
N(4)-C(6)  1.4684 H(10A)-N(10)-H(10B) 120 
N(8)-C(11)  1.3444 C(12)-N(10)-H(10A) 120 
N(8)-C(12)  1.3314 C(12)-N(10)-H(10B) 120 
N(3)-H(3A)  0.86 H(9B)-O(9)-H(9C) 104.3 
N(3)-C(5)  1.3984 H(1A)-N(1)-H(1B) 131 
N(3)-C(4)  1.3724 C(4)-N(1)-H(1A) 110.1 
N(10)-H(10A)  0.86 C(4)-N(1)-H(1B) 1122 
N(10)-H(10B)  0.86 N(6)-C(10)-C(13) 132.93 
N(10)-C(12)  1.3334 C(11)-C(10)-N(6) 109.53 
O(9)-H(9B)  0.8518 C(11)-C(10)-C(13) 117.53 
O(9)-H(9C)  0.8513 N(7)-C(11)-C(10) 105.93 
N(1)-H(1A)  0.8626 N(8)-C(11)-N(7) 124.23 
N(1)-C(4)  1.3454 N(8)-C(11)-C(10) 129.83 
N(1)-H(1B)  0.85119 N(2)-C(3)-N(4) 126.53 
C(10)-C(11)  1.3814 N(2)-C(3)-C(2) 127.43 
C(10)-C(13)  1.4214 C(2)-C(3)-N(4) 106.03 
C(3)-C(2)  1.3644 N(5)-C(1)-N(4) 111.93 
C(1)-H(1)  0.93 N(5)-C(1)-H(1) 124.1 
C(2)-C(5)  1.4164 N(4)-C(1)-H(1) 124.1 
C(14)-H(14A)  0.97 O(4)-C(13)-N(9) 119.73 
C(14)-H(14B)  0.97 O(4)-C(13)-C(10) 128.53 
C(9)-H(9A)  0.93 N(9)-C(13)-C(10) 111.83 
C(6)-H(6A)  0.97 N(5)-C(2)-C(5) 129.33 
C(6)-H(6B)  0.97 C(3)-C(2)-N(5) 110.13 
C(6)-O(2B)  1.3425 C(3)-C(2)-C(5) 120.63 
C(6)-O(2A)  1.5018 O(1)-C(5)-N(3) 122.33 
C(15)-H(15A)  0.97 O(1)-C(5)-C(2) 127.53 
C(15)-H(15B)  0.97 N(3)-C(5)-C(2) 110.23 
C(15)-C(16)  1.4915 N(8)-C(12)-N(9) 122.53 
C(8)-H(8BB)  1.019 N(8)-C(12)-N(10) 119.83 
C(8)-C(7A)  1.5599 N(10)-C(12)-N(9) 117.73 
C(8)-C(7B)  1.4179 N(2)-C(4)-N(3) 123.63 
C(8)-H(8AA)  0.796 N(2)-C(4)-N(1) 119.33 
C(16)-H(16A)  0.97 N(1)-C(4)-N(3) 117.03 
C(16)-H(16B)  0.97 O(5)-C(14)-N(7) 111.12 
O(2B)-C(7B)  1.2969 O(5)-C(14)-H(14A) 109.4 
C(7A)-H(7AA)  0.93 O(5)-C(14)-H(14B) 109.4 
C(7A)-O(2A)  0.9088 N(7)-C(14)-H(14A) 109.4 














































































































Bond Lengths (Å)   Bond Angles (°)   
Cu(1)-O(8)  1.9483 O(8)-Cu(1)-O(8)#1 180.02 
Cu(1)-O(8)#1  1.9483 O(8)-Cu(1)-O(9)#1 84.8315 
Cu(1)-O(9)#1  2.4174 O(8)#1-Cu(1)-O(9)#1 95.1715 
Cu(1)-O(9)  2.4174 O(8)-Cu(1)-O(9) 95.1715 
Cu(1)-N(1)  2.0564 O(8)#1-Cu(1)-O(9) 84.8315 
Cu(1)-N(1)#1  2.0564 O(8)-Cu(1)-N(1) 86.8615 
O(1)-C(7)  1.2507 O(8)-Cu(1)-N(1)#1 93.1415 
O(8)-H(8A)  0.9297 O(8)#1-Cu(1)-N(1) 93.1415 
O(8)-H(8B)  0.9262 O(8)#1-Cu(1)-N(1)#1 86.8615 
O(4)-C(9)  1.2447 O(9)-Cu(1)-O(9)#1 180 
O(9)-H(9A)  0.9883 N(1)-Cu(1)-O(9)#1 88.6315 
O(9)-H(9B)  0.9874 N(1)#1-Cu(1)-O(9)#1 91.3715 
N(4)-H(4)  0.86 N(1)-Cu(1)-O(9) 91.3715 
N(4)-C(7)  1.3806 N(1)#1-Cu(1)-O(9) 88.6315 
N(4)-C(8)  1.3777 N(1)-Cu(1)-N(1)#1 180.02 
N(9)-H(9)  0.86 Cu(1)-O(8)-H(8A) 114.3 
N(9)-C(9)  1.3907 Cu(1)-O(8)-H(8B) 114 
N(9)-C(12)  1.3638 H(8A)-O(8)-H(8B) 99.7 
N(3)-C(2)  1.3476 Cu(1)-O(9)-H(9A) 115.3 
N(3)-C(8)  1.3198 Cu(1)-O(9)-H(9B) 115 
N(8)-C(11)  1.3387 H(9A)-O(9)-H(9B) 98.6 
N(8)-C(12)  1.3377 C(7)-N(4)-H(4) 117.4 
N(7)-C(10)  1.3926 C(8)-N(4)-H(4) 117.4 
N(7)-C(13)  1.3048 C(8)-N(4)-C(7) 125.35 
N(1)-C(3)  1.3107 C(9)-N(9)-H(9) 117 
N(1)-C(1)  1.3966 C(12)-N(9)-H(9) 117 
O(2)-C(4)  1.3878 C(12)-N(9)-C(9) 126.04 
O(2)-C(5)  1.4488 C(8)-N(3)-C(2) 112.55 
N(2)-C(2)  1.3717 C(12)-N(8)-C(11) 111.45 
N(2)-C(3)  1.3706 C(13)-N(7)-C(10) 105.25 
N(2)-C(4)  1.4677 C(3)-N(1)-Cu(1) 120.33 
C(7)-C(1)  1.4287 C(3)-N(1)-C(1) 104.84 
N(6)-C(11)  1.3797 C(1)-N(1)-Cu(1) 134.94 
N(6)-C(13)  1.3828 C(4)-O(2)-C(5) 112.75 
N(6)-C(14)  1.4749 C(2)-N(2)-C(4) 127.44 
N(5)-H(5A)  0.86 C(3)-N(2)-C(2) 107.14 
N(5)-H(5B)  0.86 C(3)-N(2)-C(4) 125.45 
N(5)-C(8)  1.3387 O(1)-C(7)-N(4) 119.45 
N(10)-H(10A)  0.86 O(1)-C(7)-C(1) 128.74 
N(10)-H(10B)  0.86 N(4)-C(7)-C(1) 112.05 
N(10)-C(12)  1.3427 C(11)-N(6)-C(13) 106.65 
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C(10)-C(9)  1.4117 C(11)-N(6)-C(14) 125.95 
C(10)-C(11)  1.3908 C(13)-N(6)-C(14) 127.55 
C(2)-C(1)  1.3777 H(5A)-N(5)-H(5B) 120 
O(5)-C(15)  1.40816 C(8)-N(5)-H(5A) 120 
O(5)-C(14)  1.37711 C(8)-N(5)-H(5B) 120 
C(3)-H(3)  0.93 H(10A)-N(10)-H(10B) 120 
O(3)-H(3A)  0.82 C(12)-N(10)-H(10A) 120 
O(3)-C(6)  1.45913 C(12)-N(10)-H(10B) 120 
C(13)-H(13)  0.93 N(7)-C(10)-C(9) 130.75 
C(4)-H(4A)  0.97 C(11)-C(10)-N(7) 110.14 
C(4)-H(4B)  0.97 C(11)-C(10)-C(9) 119.15 
C(5)-H(5C)  0.97 O(4)-C(9)-N(9) 120.95 
C(5)-H(5D)  0.97 O(4)-C(9)-C(10) 128.25 
C(5)-C(6)  1.47213 N(9)-C(9)-C(10) 110.95 
C(6)-H(6A)  0.97 N(3)-C(2)-N(2) 125.75 
C(6)-H(6B)  0.97 N(3)-C(2)-C(1) 128.75 
C(15)-H(15A)  0.97 N(2)-C(2)-C(1) 105.64 
C(15)-H(15B)  0.97 N(8)-C(11)-N(6) 125.75 
C(15)-H(15C)  0.97 N(8)-C(11)-C(10) 128.95 
C(15)-H(15D)  0.97 N(6)-C(11)-C(10) 105.45 
C(15)-C(16A)  1.552 N(3)-C(8)-N(4) 123.45 
C(15)-C(16B)  1.563 N(3)-C(8)-N(5) 120.65 
C(16A)-H(16A)  0.97 N(5)-C(8)-N(4) 116.05 
C(16A)-H(16B)  0.97 C(14)-O(5)-C(15) 115.49 
C(16A)-O(6A)  1.47315 N(1)-C(3)-N(2) 112.35 
O(6A)-H(6AA)  0.82 N(1)-C(3)-H(3) 123.8 
C(16B)-H(16C)  0.97 N(2)-C(3)-H(3) 123.8 
C(16B)-H(16D)  0.97 N(1)-C(1)-C(7) 131.75 
C(16B)-O(6B)  1.46716 C(2)-C(1)-N(1) 110.14 
O(6B)-H(6BA)  0.82 C(2)-C(1)-C(7) 118.24 
C(14)-H(14A)  0.97 C(6)-O(3)-H(3A) 109.5 
C(14)-H(14B)  0.97 N(8)-C(12)-N(9) 123.85 
O(7)-H(7A)  1.0579 N(8)-C(12)-N(10) 118.85 
O(7)-H(7B)  0.561 N(10)-C(12)-N(9) 117.35 
O(7)-H(7B)#2  0.561 N(7)-C(13)-N(6) 112.65 
O(14)-H(14C)  0.9183 N(7)-C(13)-H(13) 123.7 
O(14)-H(14D)  0.8508 N(6)-C(13)-H(13) 123.7 
O(10)-H(10C)  0.8356 O(2)-C(4)-N(2) 112.04 
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Crystal 3 
Bond Length (Å)   Bond Angles(°)   
Cu(1)-O(13)  2.266(2) N(16)-Cu(1)-O(13) 97.82(10) 
Cu(1)-N(16)  1.952(3) N(16)-Cu(1)-N(11) 88.96(10) 
Cu(1)-N(11)  2.074(2) N(16)-Cu(1)-N(1) 90.14(10) 
Cu(1)-N(1)  2.077(2) N(16)-Cu(1)-N(6) 164.27(10) 
Cu(1)-N(6)  1.963(3) N(11)-Cu(1)-O(13) 91.85(9) 
F(1)-B(1)  1.394(4) N(11)-Cu(1)-N(1) 174.68(10) 
F(6)-B(2)  1.406(4) N(1)-Cu(1)-O(13) 93.47(9) 
F(3)-B(1)  1.395(4) N(6)-Cu(1)-O(13) 97.73(10) 
F(4)-B(1)  1.391(4) N(6)-Cu(1)-N(11) 88.15(10) 
F(8)-B(2)  1.390(4) N(6)-Cu(1)-N(1) 91.31(10) 
F(2)-B(1)  1.384(4) C(22)-O(8)-C(23) 112.3(2) 
F(5)-B(2)  1.388(4) C(6)-O(1)-C(7) 113.6(2) 
O(8)-C(22)  1.392(4) C(24)-O(9)-H(9) 109.5 
O(8)-C(23)  1.436(4) C(30)-O(11)-C(31) 113.6(2) 
F(7)-B(2)  1.375(4) C(16)-O(5)-H(5) 103(3) 
O(1)-C(6)  1.401(4) C(14)-O(4)-C(15) 112.8(2) 
O(1)-C(7)  1.432(4) C(8)-O(2)-H(2) 109.5 
O(3)-C(5)  1.235(4) C(32)-O(12)-H(12) 100(4) 
O(9)-H(9)  0.82 Cu(1)-O(13)-H(13A) 109.3 
O(9)-C(24)  1.432(4) Cu(1)-O(13)-H(13B) 109.3 
O(6)-C(13)  1.234(4) H(13A)-O(13)-H(13B) 104.5 
O(11)-C(30)  1.399(4) C(4)-N(13)-C(3) 112.3(2) 
O(11)-C(31)  1.429(4) C(19)-N(3)-C(20) 112.4(2) 
O(10)-C(28)  1.231(4) C(13)-N(19)-H(19) 117.1 
O(5)-C(16)  1.429(4) C(12)-N(19)-H(19) 117.1 
O(5)-H(5)  0.77(5) C(12)-N(19)-C(13) 125.7(3) 
O(7)-C(18)  1.235(4) C(9)-N(17)-C(11) 106.4(2) 
O(4)-C(14)  1.403(4) C(9)-N(17)-C(14) 126.6(2) 
O(4)-C(15)  1.435(4) C(11)-N(17)-C(14) 126.9(3) 
O(2)-H(2)  0.82 C(12)-N(18)-C(11) 112.3(3) 
O(2)-C(8)  1.432(4) C(10)-N(16)-Cu(1) 126.5(2) 
O(12)-C(32)  1.429(4) C(9)-N(16)-Cu(1) 127.3(2) 
O(12)-H(12)  0.69(5) C(9)-N(16)-C(10) 105.8(3) 
O(13)-H(13A)  0.8514 C(1)-N(11)-Cu(1) 120.0(2) 
O(13)-H(13B)  0.8502 C(1)-N(11)-C(2) 105.0(2) 
N(13)-C(4)  1.315(4) C(2)-N(11)-Cu(1) 134.7(2) 
N(13)-C(3)  1.354(4) C(19)-N(5)-H(5A) 117.1 
N(3)-C(19)  1.317(4) C(19)-N(5)-C(18) 125.8(3) 
N(3)-C(20)  1.352(4) C(18)-N(5)-H(5A) 117.1 
N(19)-H(19)  0.86 C(20)-N(2)-C(22) 125.2(2) 
N(19)-C(13)  1.394(4) C(21)-N(2)-C(20) 106.7(2) 
N(19)-C(12)  1.372(4) C(21)-N(2)-C(22) 127.5(3) 
N(17)-C(9)  1.359(4) C(1)-N(12)-C(6) 125.4(3) 
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N(17)-C(11)  1.383(4) C(3)-N(12)-C(1) 106.6(2) 
N(17)-C(14)  1.465(4) C(3)-N(12)-C(6) 126.7(2) 
N(18)-C(12)  1.322(4) C(27)-N(7)-C(30) 126.4(3) 
N(18)-C(11)  1.357(4) C(25)-N(7)-C(27) 107.1(2) 
N(16)-C(10)  1.386(4) C(25)-N(7)-C(30) 126.6(3) 
N(16)-C(9)  1.316(4) C(17)-N(1)-Cu(1) 135.0(2) 
N(11)-C(1)  1.314(4) C(21)-N(1)-Cu(1) 119.7(2) 
N(11)-C(2)  1.403(4) C(21)-N(1)-C(17) 104.8(2) 
N(5)-H(5A)  0.86 C(25)-N(6)-Cu(1) 125.4(2) 
N(5)-C(19)  1.373(4) C(25)-N(6)-C(26) 105.7(3) 
N(5)-C(18)  1.398(4) C(26)-N(6)-Cu(1) 127.7(2) 
N(2)-C(20)  1.368(4) C(4)-N(15)-H(15A) 125(3) 
N(2)-C(21)  1.364(4) C(4)-N(15)-H(15B) 112(3) 
N(2)-C(22)  1.464(4) H(15A)-N(15)-H(15B) 122(4) 
N(12)-C(1)  1.371(4) C(29)-N(9)-H(9A) 117.1 
N(12)-C(3)  1.367(4) C(29)-N(9)-C(28) 125.8(3) 
N(12)-C(6)  1.463(4) C(28)-N(9)-H(9A) 117.1 
N(7)-C(27)  1.379(4) C(4)-N(14)-H(14) 117.4 
N(7)-C(25)  1.360(4) C(4)-N(14)-C(5) 125.2(3) 
N(7)-C(30)  1.469(4) C(5)-N(14)-H(14) 117.4 
N(1)-C(17)  1.403(4) C(29)-N(8)-C(27) 111.8(3) 
N(1)-C(21)  1.315(4) H(4A)-N(4)-H(4B) 120 
N(6)-C(25)  1.312(4) C(19)-N(4)-H(4A) 120 
N(6)-C(26)  1.396(4) C(19)-N(4)-H(4B) 120 
N(15)-C(4)  1.347(4) H(20A)-N(20)-H(20B) 120 
N(15)-H(15A)  0.74(4) C(12)-N(20)-H(20A) 120 
N(15)-H(15B)  0.85(4) C(12)-N(20)-H(20B) 120 
N(9)-H(9A)  0.86 H(10A)-N(10)-H(10B) 120 
N(9)-C(29)  1.368(4) C(29)-N(10)-H(10A) 120 
N(9)-C(28)  1.404(4) C(29)-N(10)-H(10B) 120 
N(14)-H(14)  0.86 N(11)-C(1)-N(12) 112.5(3) 
N(14)-C(4)  1.377(4) N(11)-C(1)-H(1) 123.7 
N(14)-C(5)  1.402(4) N(12)-C(1)-H(1) 123.7 
N(8)-C(27)  1.349(4) N(3)-C(19)-N(5) 123.1(3) 
N(8)-C(29)  1.322(4) N(3)-C(19)-N(4) 119.3(3) 
N(4)-H(4A)  0.86 N(4)-C(19)-N(5) 117.6(3) 
N(4)-H(4B)  0.86 N(3)-C(20)-N(2) 124.2(3) 
N(4)-C(19)  1.346(4) N(3)-C(20)-C(17) 129.3(3) 
N(20)-H(20A)  0.86 N(2)-C(20)-C(17) 106.5(2) 
N(20)-H(20B)  0.86 N(7)-C(27)-C(26) 106.0(3) 
N(20)-C(12)  1.344(4) N(8)-C(27)-N(7) 125.3(3) 
N(10)-H(10A)  0.86 N(8)-C(27)-C(26) 128.8(3) 
N(10)-H(10B)  0.86 O(6)-C(13)-N(19) 121.0(3) 
N(10)-C(29)  1.349(4) O(6)-C(13)-C(10) 128.0(3) 
C(1)-H(1)  0.93 N(19)-C(13)-C(10) 110.9(3) 
C(20)-C(17)  1.392(4) N(18)-C(12)-N(19) 123.4(3) 
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C(27)-C(26)  1.380(4) N(18)-C(12)-N(20) 119.7(3) 
C(13)-C(10)  1.424(4) N(20)-C(12)-N(19) 116.9(3) 
C(10)-C(11)  1.374(4) N(16)-C(10)-C(13) 131.1(3) 
C(25)-H(25)  0.93 C(11)-C(10)-N(16) 109.1(3) 
C(9)-H(9B)  0.93 C(11)-C(10)-C(13) 119.3(3) 
C(5)-C(2)  1.422(4) N(13)-C(4)-N(15) 119.2(3) 
C(17)-C(18)  1.421(4) N(13)-C(4)-N(14) 123.4(3) 
C(3)-C(2)  1.378(4) N(15)-C(4)-N(14) 117.4(3) 
C(26)-C(28)  1.422(4) N(7)-C(25)-H(25) 123.9 
C(6)-H(6A)  0.97(4) N(6)-C(25)-N(7) 112.1(3) 
C(6)-H(6B)  1.06(4) N(6)-C(25)-H(25) 123.9 
C(21)-H(21)  0.93 N(17)-C(9)-H(9B) 123.9 
C(30)-H(30A)  0.97 N(16)-C(9)-N(17) 112.1(3) 
C(30)-H(30B)  0.97 N(16)-C(9)-H(9B) 123.9 
C(22)-H(22A)  0.97 O(3)-C(5)-N(14) 119.5(3) 
C(22)-H(22B)  0.97 O(3)-C(5)-C(2) 128.9(3) 
C(24)-H(24A)  0.97 N(14)-C(5)-C(2) 111.6(2) 
C(24)-H(24B)  0.97 N(1)-C(17)-C(18) 133.7(3) 
C(24)-C(23)  1.506(4) C(20)-C(17)-N(1) 108.9(3) 
C(23)-H(23A)  0.97 C(20)-C(17)-C(18) 117.3(3) 
C(23)-H(23B)  0.97 N(18)-C(11)-N(17) 125.3(3) 
C(14)-H(14A)  0.93 N(18)-C(11)-C(10) 128.2(3) 
C(16)-H(16A)  0.97 C(10)-C(11)-N(17) 106.5(3) 
C(16)-H(16B)  0.97 N(13)-C(3)-N(12) 124.0(3) 
C(16)-C(15)  1.505(4) N(13)-C(3)-C(2) 129.2(3) 
C(32)-H(32A)  0.97 N(12)-C(3)-C(2) 106.8(3) 
C(32)-H(32B)  0.97 O(7)-C(18)-N(5) 119.1(3) 
C(32)-C(31)  1.507(5) O(7)-C(18)-C(17) 129.0(3) 
C(8)-H(8A)  0.97 N(5)-C(18)-C(17) 111.9(2) 
C(8)-H(8B)  0.97 N(11)-C(2)-C(5) 132.9(3) 
C(8)-C(7)  1.500(4) C(3)-C(2)-N(11) 109.1(3) 
C(15)-H(15C)  0.97 C(3)-C(2)-C(5) 117.9(3) 
C(15)-H(15D)  0.97 N(6)-C(26)-C(28) 131.4(3) 
C(7)-H(7A)  0.97 C(27)-C(26)-N(6) 109.2(3) 
C(7)-H(7B)  0.97 C(27)-C(26)-C(28) 119.2(3) 
C(31)-H(31A)  0.97 O(1)-C(6)-N(12) 110.8(2) 




















































































































































































  F(7)-B(2)-F(5) 109.3(3) 
Table 24 
Crystal 4 
Bond Lengths (Å)   Bond Angles (°)   
Cu(1)-O(4)  1.9562 O(4)-Cu(1)-O(4)#1 180 
Cu(1)-O(4)#1  1.9562 O(4)-Cu(1)-N(4) 88.531 
Cu(1)-N(4)#1  2.0023 O(4)-Cu(1)-N(4)#1 91.471 
Cu(1)-N(4)  2.0023 O(4)#1-Cu(1)-N(4) 91.471 
O(2)-C(6)  1.3855 O(4)#1-Cu(1)-N(4)#1 88.531 
O(2)-C(7)  1.4374 N(4)#1-Cu(1)-N(4) 180.008 
O(4)-H(4A)  0.8576 C(6)-O(2)-C(7) 114.33 
O(4)-H(4B)  0.8571 Cu(1)-O(4)-H(4A) 109.5 
O(1)-C(2)  1.2384 Cu(1)-O(4)-H(4B) 109.9 
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F(1)-B(1)  1.3826 H(4A)-O(4)-H(4B) 103.9 
F(4)-B(1)  1.3796 C(1)-N(2)-C(4) 112.93 
F(3)-B(1)  1.3936 C(4)-N(5)-C(6) 124.83 
N(2)-C(4)  1.3444 C(5)-N(5)-C(4) 107.23 
N(2)-C(1)  1.3365 C(5)-N(5)-C(6) 128.03 
N(5)-C(4)  1.3734 C(1)-N(3)-H(3) 117.4 
N(5)-C(6)  1.4794 C(2)-N(3)-H(3) 117.4 
N(5)-C(5)  1.3675 C(2)-N(3)-C(1) 125.23 
N(3)-H(3)  0.86 C(3)-N(4)-Cu(1) 111.22 
N(3)-C(1)  1.3794 C(5)-N(4)-Cu(1) 143.63 
N(3)-C(2)  1.3754 C(5)-N(4)-C(3) 104.83 
F(2)-B(1)  1.3726 C(8)-O(3)-H(3A) 109.5 
N(4)-C(3)  1.3904 H(1A)-N(1)-H(1B) 120 
N(4)-C(5)  1.3104 C(1)-N(1)-H(1A) 120 
O(3)-H(3A)  0.82 C(1)-N(1)-H(1B) 120 
O(3)-C(8)  1.4245 N(2)-C(4)-N(5) 127.93 
N(1)-H(1A)  0.86 N(2)-C(4)-C(3) 126.83 
N(1)-H(1B)  0.86 C(3)-C(4)-N(5) 105.33 
N(1)-C(1)  1.3165 N(4)-C(3)-C(2) 128.73 
C(4)-C(3)  1.3725 C(4)-C(3)-N(4) 110.53 
C(3)-C(2)  1.4085 C(4)-C(3)-C(2) 120.83 
C(6)-H(6A)  1.004 N(2)-C(1)-N(3) 123.03 
C(6)-H(6B)  1.045 N(1)-C(1)-N(2) 119.83 
C(5)-H(5)  0.93 N(1)-C(1)-N(3) 117.13 
C(7)-H(7A)  0.97 O(1)-C(2)-N(3) 123.63 
C(7)-H(7B)  0.97 O(1)-C(2)-C(3) 125.13 
C(7)-C(8)  1.4756 N(3)-C(2)-C(3) 111.33 
C(8)-H(8A)  0.97 O(2)-C(6)-N(5) 111.63 
























































Bond Lengths (Å)   Bond Angle (°)   
Cu1-F2  1.9562 F2-Cu1-F2#1 180 
Cu1-F2#1  1.9562 F2-Cu1-N1 90.119 
Cu1-N1#1  1.9822 F2#1-Cu1-N1 89.899 
Cu1-N1  1.9822 F2-Cu1-N1#1 89.899 
F4-B1  1.3934 F2#1-Cu1-N1#1 90.119 
F1-B1  1.3964 N1#1-Cu1-N1 180 
F3-B1  1.3784 B1-F2-Cu1 125.72 
F2-B1  1.4834 C6-O2-C7 113.33 
O2-C6  1.3904 C4-N4-H4 117.4 
O2-C7  1.4364 C5-N4-H4 117.4 
O1-C4  1.2284 C5-N4-C4 125.13 
O4-C9  1.2344 C2-N1-Cu1 124.12 
N4-H4  0.86 C1-N1-Cu1 130.12 
N4-C4  1.3984 C1-N1-C2 105.82 
N4-C5  1.3714 C14-O5-C15 113.33 
N1-C2  1.3924 C1-N2-C3 106.42 
N1-C1  1.3084 C1-N2-C6 126.83 
O5-C14  1.3845 C3-N2-C6 126.73 
O5-C15  1.3955 C11-N7-C14 126.13 
N2-C1  1.3664 C13-N7-C11 106.13 
N2-C3  1.3764 C13-N7-C14 127.73 
N2-C6  1.4674 C5-N3-C3 112.23 
N7-C11  1.3784 C12-N8-C11 112.23 
N7-C13  1.3764 C13-N6-C10 104.33 
N7-C14  1.4584 C12-N9-C9 125.33 
N3-C5  1.3314 H5A-N5-H5B 120 
N3-C3  1.3484 C5-N5-H5A 120 
N8-C12  1.3244 C5-N5-H5B 120 
N8-C11  1.3514 H10A-N10-H10B 123.7 
N6-C13  1.3014 C12-N10-H10A 109.8 
N6-C10  1.3924 C12-N10-H10B 1213 
N9-C12  1.3704 N1-C2-C4 130.93 
N9-C9  1.3914 C3-C2-N1 108.93 
N5-H5A  0.86 C3-C2-C4 120.23 
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N5-H5B  0.86 O1-C4-N4 120.93 
N5-C5  1.3404 O1-C4-C2 128.33 
N10-H10A  0.863 N4-C4-C2 110.82 
N10-C12  1.3444 C16-O6-H6 109.5 
N10-H10B  0.745 N1-C1-N2 112.33 
C2-C4  1.4164 N1-C1-H1 123.9 
C2-C3  1.3754 N2-C1-H1 123.9 
O6-H6  0.82 N3-C5-N4 123.93 
O6-C16  1.4155 N3-C5-N5 119.53 
C1-H1  0.93 N5-C5-N4 116.63 
C9-C10  1.4165 N3-C3-N2 125.53 
C11-C10  1.3795 N3-C3-C2 127.83 
C13-H13  0.93 C2-C3-N2 106.62 
C14-H14A  1.014 N8-C12-N9 123.83 
C14-H14B  0.944 N8-C12-N10 119.93 
C6-H6A  0.97 N10-C12-N9 116.33 
C6-H6B  0.97 O4-C9-N9 120.23 
O3B-H3B  0.82 O4-C9-C10 128.33 
O3B-C8  1.4496 N9-C9-C10 111.43 
C7-H7A  0.97 N7-C11-C10 105.53 
C7-H7B  0.97 N8-C11-N7 126.33 
C7-C8  1.4765 N8-C11-C10 128.13 
C16-H16A  0.97 N7-C13-H13 123.3 
C16-H16B  0.97 N6-C13-N7 113.53 
C16-C15  1.4996 N6-C13-H13 123.3 
C8-H8AA  0.97 N6-C10-C9 130.23 
C8-H8AB  0.97 C11-C10-N6 110.63 
C8-H8A  0.97 C11-C10-C9 119.23 
C8-H8B  0.97 O5-C14-N7 113.83 
C8-O3A  1.812 O5-C14-H14A 1052 
C15-H15A  0.97 O5-C14-H14B 1132 
C15-H15B  0.97 N7-C14-H14A 1102 
O8-H8C  0.8502 N7-C14-H14B 1072 
O8-H8D  0.8497 H14A-C14-H14B 1073 
O7-H7C  0.8504 O2-C6-N2 111.93 
O7-H7D  0.8492 O2-C6-H6A 109.2 




























































































Bond Length (Å)   Bond Angles (°)   
Zn(1)-N(16)  2.0102 N(11)-Zn(1)-N(16) 105.959 
Zn(1)-N(11)  2.0082 N(1)-Zn(1)-N(16) 118.531 
Zn(1)-N(1)  1.9872 N(1)-Zn(1)-N(11) 107.391 
Zn(1)-N(6)  1.9882 N(1)-Zn(1)-N(6) 107.851 
Si(1)-F(6)  1.6802 N(6)-Zn(1)-N(16) 102.399 
Si(1)-F(4)  1.6772 N(6)-Zn(1)-N(11) 115.079 
Si(1)-F(3)  1.6893 F(6)-Si(1)-F(3) 90.1414 
Si(1)-F(1)  1.6693 F(4)-Si(1)-F(6) 90.2112 
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Si(1)-F(2)  1.6763 F(4)-Si(1)-F(3) 88.3413 
Si(1)-F(5)  1.6613 F(1)-Si(1)-F(6) 88.7713 
O(5)-C(14)  1.3954 F(1)-Si(1)-F(4) 177.3618 
O(5)-C(15)  1.4444 F(1)-Si(1)-F(3) 89.2315 
O(7)-C(20)  1.2264 F(1)-Si(1)-F(2) 91.2615 
O(11)-C(30)  1.3804 F(2)-Si(1)-F(6) 178.9716 
O(11)-C(31)  1.4385 F(2)-Si(1)-F(4) 89.7215 
O(10)-C(28)  1.2314 F(2)-Si(1)-F(3) 88.8315 
O(1)-C(4)  1.2304 F(5)-Si(1)-F(6) 91.2014 
O(4)-C(12)  1.2334 F(5)-Si(1)-F(4) 91.7618 
O(2)-C(6)  1.3864 F(5)-Si(1)-F(3) 178.6516 
O(2)-C(7)  1.4394 F(5)-Si(1)-F(1) 90.6919 
N(16)-C(9)  1.3104 F(5)-Si(1)-F(2) 89.8215 
N(16)-C(10)  1.3924 C(14)-O(5)-C(15) 114.22 
O(13)-H(13A)  0.8504 C(30)-O(11)-C(31) 116.23 
O(13)-H(13B)  0.85 C(6)-O(2)-C(7) 112.83 
O(8)-C(22)  1.3904 C(9)-N(16)-Zn(1) 128.32 
O(8)-C(23)  1.4374 C(9)-N(16)-C(10) 105.52 
N(11)-C(2)  1.3894 C(10)-N(16)-Zn(1) 125.2018 
N(11)-C(1)  1.3094 H(13A)-O(13)-H(13B) 104.5 
N(17)-C(9)  1.3704 C(22)-O(8)-C(23) 112.93 
N(17)-C(11)  1.3814 C(2)-N(11)-Zn(1) 120.7518 
N(17)-C(14)  1.4673 C(1)-N(11)-Zn(1) 132.62 
N(12)-C(3)  1.3844 C(1)-N(11)-C(2) 105.42 
N(12)-C(1)  1.3634 C(9)-N(17)-C(11) 107.02 
N(12)-C(6)  1.4664 C(9)-N(17)-C(14) 126.82 
N(3)-C(19)  1.3534 C(11)-N(17)-C(14) 126.02 
N(3)-C(21)  1.3294 C(3)-N(12)-C(6) 126.92 
N(14)-H(14)  0.86 C(1)-N(12)-C(3) 107.42 
N(14)-C(5)  1.3794 C(1)-N(12)-C(6) 125.63 
N(14)-C(4)  1.3954 C(21)-N(3)-C(19) 112.33 
N(1)-C(18)  1.3863 C(5)-N(14)-H(14) 117.3 
N(1)-C(17)  1.3174 C(5)-N(14)-C(4) 125.42 
N(13)-C(3)  1.3534 C(4)-N(14)-H(14) 117.3 
N(13)-C(5)  1.3294 C(18)-N(1)-Zn(1) 125.4819 
N(6)-C(27)  1.3784 C(17)-N(1)-Zn(1) 128.3019 
N(6)-C(25)  1.3094 C(17)-N(1)-C(18) 105.42 
N(7)-C(26)  1.3774 C(5)-N(13)-C(3) 112.12 
N(7)-C(25)  1.3644 C(27)-N(6)-Zn(1) 127.1818 
N(7)-C(30)  1.4674 C(25)-N(6)-Zn(1) 127.02 
N(2)-C(19)  1.3824 C(25)-N(6)-C(27) 105.72 
N(2)-C(17)  1.3644 C(26)-N(7)-C(30) 127.92 
N(2)-C(22)  1.4624 C(25)-N(7)-C(26) 107.02 
N(18)-C(11)  1.3514 C(25)-N(7)-C(30) 125.12 
N(18)-C(13)  1.3324 C(19)-N(2)-C(22) 127.02 
N(20)-H(20A)  0.86 C(17)-N(2)-C(19) 106.92 
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N(20)-H(20B)  0.86 C(17)-N(2)-C(22) 126.02 
N(20)-C(13)  1.3364 C(13)-N(18)-C(11) 112.02 
N(15)-H(15A)  0.86 H(20A)-N(20)-H(20B) 120 
N(15)-H(15B)  0.86 C(13)-N(20)-H(20A) 120 
N(15)-C(5)  1.3394 C(13)-N(20)-H(20B) 120 
N(4)-H(4)  0.86 H(15A)-N(15)-H(15B) 120 
N(4)-C(20)  1.3874 C(5)-N(15)-H(15A) 120 
N(4)-C(21)  1.3714 C(5)-N(15)-H(15B) 120 
O(3)-H(3)  0.82 C(20)-N(4)-H(4) 117.2 
O(3)-C(8)  1.4105 C(21)-N(4)-H(4) 117.2 
N(19)-H(19)  0.86 C(21)-N(4)-C(20) 125.53 
N(19)-C(12)  1.3954 C(8)-O(3)-H(3) 109.5 
N(19)-C(13)  1.3734 C(12)-N(19)-H(19) 117.1 
N(8)-C(26)  1.3554 C(13)-N(19)-H(19) 117.1 
N(8)-C(29)  1.3314 C(13)-N(19)-C(12) 125.83 
N(9)-H(9)  0.86 C(29)-N(8)-C(26) 111.92 
N(9)-C(28)  1.3864 C(28)-N(9)-H(9) 117.3 
N(9)-C(29)  1.3694 C(29)-N(9)-H(9) 117.3 
O(6)-H(6)  0.82 C(29)-N(9)-C(28) 125.32 
O(6)-C(16)  1.4145 C(16)-O(6)-H(6) 109.5 
C(9)-H(9A)  0.93 N(16)-C(9)-N(17) 112.12 
C(2)-C(3)  1.3764 N(16)-C(9)-H(9A) 124 
C(2)-C(4)  1.4194 N(17)-C(9)-H(9A) 124 
C(27)-C(26)  1.3724 N(11)-C(2)-C(4) 129.52 
C(27)-C(28)  1.4164 C(3)-C(2)-N(11) 110.32 
C(12)-C(10)  1.4184 C(3)-C(2)-C(4) 119.93 
C(11)-C(10)  1.3804 N(6)-C(27)-C(28) 129.63 
N(5)-H(5A)  0.86 C(26)-C(27)-N(6) 110.12 
N(5)-H(5B)  0.86 C(26)-C(27)-C(28) 120.23 
N(5)-C(21)  1.3404 N(13)-C(3)-N(12) 126.92 
N(10)-H(10A)  0.86 N(13)-C(3)-C(2) 128.13 
N(10)-H(10B)  0.86 C(2)-C(3)-N(12) 104.92 
N(10)-C(29)  1.3294 O(4)-C(12)-N(19) 120.93 
C(19)-C(18)  1.3744 O(4)-C(12)-C(10) 128.03 
C(18)-C(20)  1.4174 N(19)-C(12)-C(10) 111.02 
C(1)-H(1)  0.93 N(18)-C(11)-N(17) 125.92 
C(25)-H(25)  0.93 N(18)-C(11)-C(10) 128.63 
C(17)-H(17)  0.93 C(10)-C(11)-N(17) 105.52 
C(14)-H(14A)  0.97 H(5A)-N(5)-H(5B) 120 
C(14)-H(14B)  0.97 C(21)-N(5)-H(5A) 120 
O(16)-H(16)  0.82 C(21)-N(5)-H(5B) 120 
O(16)-C(34)  1.4337 N(16)-C(10)-C(12) 130.82 
C(22)-H(22A)  0.97 C(11)-C(10)-N(16) 109.92 
C(22)-H(22B)  0.97 C(11)-C(10)-C(12) 119.23 
C(30)-H(30A)  0.97 H(10A)-N(10)-H(10B) 120 
C(30)-H(30B)  0.97 C(29)-N(10)-H(10A) 120 
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O(9)-H(9B)  0.82 C(29)-N(10)-H(10B) 120 
O(9)-C(24)  1.4267 N(3)-C(19)-N(2) 126.63 
O(14)-H(14C)  0.8495 N(3)-C(19)-C(18) 127.73 
O(14)-H(14D)  0.8498 C(18)-C(19)-N(2) 105.72 
C(6)-H(6A)  0.97 N(13)-C(5)-N(14) 123.63 
C(6)-H(6B)  0.97 N(13)-C(5)-N(15) 120.83 
C(15)-H(15C)  0.97 N(15)-C(5)-N(14) 115.53 
C(15)-H(15D)  0.97 N(1)-C(18)-C(20) 130.13 
C(15)-C(16)  1.4915 C(19)-C(18)-N(1) 110.02 
C(7)-H(7A)  0.97 C(19)-C(18)-C(20) 119.93 
C(7)-H(7B)  0.97 N(8)-C(26)-N(7) 127.03 
C(7)-C(8)  1.5055 N(8)-C(26)-C(27) 127.63 
C(8)-H(8A)  0.97 C(27)-C(26)-N(7) 105.52 
C(8)-H(8B)  0.97 O(10)-C(28)-N(9) 122.43 
C(16)-H(16A)  0.97 O(10)-C(28)-C(27) 126.83 
C(16)-H(16B)  0.97 N(9)-C(28)-C(27) 110.82 
O(12)-H(12)  0.82 N(11)-C(1)-N(12) 112.03 
O(12)-C(32)  1.4026 N(11)-C(1)-H(1) 124 
C(23)-H(23A)  0.97 N(12)-C(1)-H(1) 124 
C(23)-H(23B)  0.97 N(18)-C(13)-N(20) 120.73 
C(23)-C(24)  1.5066 N(18)-C(13)-N(19) 123.33 
C(32)-H(32A)  0.97 N(20)-C(13)-N(19) 116.03 
C(32)-H(32B)  0.97 N(6)-C(25)-N(7) 111.72 
C(32)-C(31)  1.4975 N(6)-C(25)-H(25) 124.2 
C(31)-H(31A)  0.97 N(7)-C(25)-H(25) 124.2 
C(31)-H(31B)  0.97 N(1)-C(17)-N(2) 112.02 
C(24)-H(24A)  0.97 N(1)-C(17)-H(17) 124 
C(24)-H(24B)  0.97 N(2)-C(17)-H(17) 124 
C(34)-H(34A)  0.97 O(1)-C(4)-N(14) 121.23 
C(34)-H(34B)  0.97 O(1)-C(4)-C(2) 127.93 
C(34)-C(33)  1.5529 N(14)-C(4)-C(2) 110.82 
C(33)-H(33A)  0.96 O(7)-C(20)-N(4) 121.73 
C(33)-H(33B)  0.96 O(7)-C(20)-C(18) 127.23 




































































































































































































Bond Lengths (Å)   Bond Angle (°)   
Ag(01)-N(00G)  2.11311 N(00R)-Ag(01)-N(00G) 170.44 
Ag(01)-N(00R)  2.10912 N(00N)-Ag(02)-N(00T) 168.94 
Ag(02)-N(00N)  2.1261 N(00Q)-Ag(03)-N(00X) 168.65 
Ag(02)-N(00T)  2.15111 N(01I)-Ag(04)-N(01B) 169.05 
Ag(03)-N(00Q)  2.14411 F(00O)-Si(00)-F(01O) 90.16 
Ag(03)-N(00X)  2.13013 F(00O)-Si(00)-F(025) 177.86 
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Ag(04)-N(01B)  2.12813 F(00O)-Si(00)-F(02E) 90.47 
Ag(04)-N(01I)  2.11612 F(00O)-Si(00)-F(02N) 90.26 
Si(00)-F(00O)  1.65111 F(01O)-Si(00)-F(025) 88.67 
Si(00)-F(01O)  1.66813 F(01O)-Si(00)-F(02N) 177.97 
Si(00)-F(01T)  1.66014 F(01T)-Si(00)-F(00O) 90.06 
Si(00)-F(025)  1.67214 F(01T)-Si(00)-F(01O) 92.17 
Si(00)-F(02E)  1.65415 F(01T)-Si(00)-F(025) 88.27 
Si(00)-F(02N)  1.67115 F(01T)-Si(00)-F(02E) 179.68 
Si(0A)-F(00F)  1.66811 F(01T)-Si(00)-F(02N) 85.87 
Si(0A)-F(013)  1.65214 F(02E)-Si(00)-F(01O) 87.87 
Si(0A)-F(01D)  1.64916 F(02E)-Si(00)-F(025) 91.47 
Si(0A)-F(01Z)  1.552 F(02E)-Si(00)-F(02N) 94.37 
Si(0A)-F(02A)  1.74118 F(02N)-Si(00)-F(025) 90.97 
Si(0A)-F(02O)  1.692 F(00F)-Si(0A)-F(013) 88.86 
O(007)-C(026)  1.20718 F(00F)-Si(0A)-F(01D) 90.27 
O(008)-C(02C)  1.39115 F(00F)-Si(0A)-F(02A) 170.38 
O(008)-C(02R)  1.46716 F(00F)-Si(0A)-F(02O) 87.69 
O(009)-C(028)  1.37718 F(013)-Si(0A)-F(02A) 84.28 
O(009)-C(02X)  1.452 F(013)-Si(0A)-F(02O) 90.81 
N(00A)-C(019)  1.32317 F(01D)-Si(0A)-F(013) 86.68 
N(00A)-C(02M)  1.35817 F(01D)-Si(0A)-F(02A) 96.09 
N(00B)-C(01K)  1.38817 F(01D)-Si(0A)-F(02O) 176.711 
N(00B)-C(01L)  1.41217 F(01Z)-Si(0A)-F(00F) 93.89 
O(00C)-C(01Y)  1.24616 F(01Z)-Si(0A)-F(013) 171.91 
O(00D)-C(01U)  1.25015 F(01Z)-Si(0A)-F(01D) 101.01 
O(00E)-C(02Z)  1.432 F(01Z)-Si(0A)-F(02A) 92.31 
O(00E)-C(031)  1.41118 F(01Z)-Si(0A)-F(02O) 81.612 
N(00G)-C(018)  1.31717 F(02O)-Si(0A)-F(02A) 85.91 
N(00G)-C(027)  1.39518 C(02C)-O(008)-C(02R) 114.21 
N(00H)-C(01G)  1.38917 C(028)-O(009)-C(02X) 114.213 
N(00H)-C(01U)  1.39617 C(019)-N(00A)-C(02M) 113.411 
O(00I)-C(029)  1.22219 C(01K)-N(00B)-C(01L) 124.611 
N(00J)-C(017)  1.40216 C(031)-O(00E)-C(02Z) 113.912 
N(00J)-C(02C)  1.45417 C(018)-N(00G)-Ag(01) 123.99 
N(00J)-C(02M)  1.35517 C(018)-N(00G)-C(027) 106.211 
N(00K)-C(01L)  1.32316 C(027)-N(00G)-Ag(01) 129.99 
N(00K)-C(01W)  1.33117 C(01G)-N(00H)-C(01U) 125.111 
N(00L)-C(01G)  1.32418 C(017)-N(00J)-C(02C) 124.511 
N(00M)-C(018)  1.37317 C(02M)-N(00J)-C(017) 106.711 
N(00M)-C(01P)  1.41117 C(02M)-N(00J)-C(02C) 127.411 
N(00M)-C(028)  1.47719 C(01L)-N(00K)-C(01W) 113.211 
N(00N)-C(017)  1.31816 C(018)-N(00M)-C(01P) 105.311 
N(00N)-C(01R)  1.38117 C(018)-N(00M)-C(028) 126.612 
O(00P)-C(039)  1.24619 C(01P)-N(00M)-C(028) 127.312 
N(00Q)-C(01G)  1.33118 C(017)-N(00N)-Ag(02) 134.99 
N(00Q)-C(02I)  1.38617 C(017)-N(00N)-C(01R) 105.81 
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N(00R)-C(01J)  1.34918 C(01R)-N(00N)-Ag(02) 119.18 
N(00R)-C(02D)  1.35518 C(01G)-N(00Q)-Ag(03) 122.89 
N(00S)-C(01J)  1.36317 C(01G)-N(00Q)-C(02I) 114.111 
N(00S)-C(01V)  1.34417 C(02I)-N(00Q)-Ag(03) 122.99 
N(00S)-C(020)  1.48718 C(01J)-N(00R)-Ag(01) 125.99 
N(00T)-C(01P)  1.34517 C(01J)-N(00R)-C(02D) 105.412 
N(00T)-C(02F)  1.32918 C(02D)-N(00R)-Ag(01) 127.89 
O(00U)-C(01K)  1.24016 C(01J)-N(00S)-C(020) 124.011 
O(00V)-C(020)  1.40618 C(01V)-N(00S)-C(01J) 108.511 
O(00V)-C(037)  1.43419 C(01V)-N(00S)-C(020) 127.011 
N(00W)-C(02P)  1.33919 C(01P)-N(00T)-Ag(02) 124.09 
N(00X)-C(024)  1.392 C(02F)-N(00T)-Ag(02) 122.49 
N(00X)-C(02K)  1.312 C(02F)-N(00T)-C(01P) 113.012 
O(00Y)-C(033)  1.442 C(020)-O(00V)-C(037) 111.811 
N(00Z)-C(026)  1.40719 C(024)-N(00X)-Ag(03) 117.41 
N(00Z)-C(02P)  1.36619 C(02K)-N(00X)-Ag(03) 135.812 
N(010)-C(019)  1.39117 C(02K)-N(00X)-C(024) 106.114 
N(010)-C(01Y)  1.38516 C(02P)-N(00Z)-C(026) 126.412 
N(011)-C(02B)  1.362 C(019)-N(010)-C(01Y) 125.411 
O(012)-C(035)  1.442 C(030)-O(014)-C(02S) 115.615 
O(014)-C(02S)  1.362 C(02Y)-O(015)-C(03B) 112.513 
O(014)-C(030)  1.382 N(00N)-C(017)-N(00J) 110.911 
O(015)-C(02Y)  1.41717 N(00G)-C(018)-N(00M) 112.912 
O(015)-C(03B)  1.412 N(00A)-C(019)-N(010) 123.212 
C(019)-N(02G)  1.33019 N(00A)-C(019)-N(02G) 120.312 
O(01A)-C(02T)  1.44718 N(02G)-C(019)-N(010) 116.412 
N(01B)-C(01X)  1.39518 C(01X)-N(01B)-Ag(04) 128.71 
N(01B)-C(02L)  1.352 C(02L)-N(01B)-Ag(04) 124.61 
N(01C)-C(01V)  1.37518 C(02L)-N(01B)-C(01X) 106.612 
N(01C)-C(02B)  1.32619 C(02B)-N(01C)-C(01V) 111.912 
N(01E)-C(01W)  1.42119 C(01W)-N(01E)-C(031) 126.512 
N(01E)-C(02W)  1.38619 C(02W)-N(01E)-C(01W) 106.612 
N(01E)-C(031)  1.462 C(02W)-N(01E)-C(031) 126.513 
O(01F)-C(038)  1.422 N(00L)-C(01G)-N(00H) 116.512 
C(01H)-N(023)  1.37319 N(00Q)-C(01G)-N(00H) 122.412 
C(01H)-C(024)  1.382 N(00Q)-C(01G)-N(00L) 121.113 
C(01H)-N(02J)  1.37419 N(023)-C(01H)-C(024) 107.413 
N(01I)-C(01Q)  1.38518 N(023)-C(01H)-N(02J) 125.013 
N(01I)-C(02W)  1.322 N(02J)-C(01H)-C(024) 127.613 
C(01K)-C(01Q)  1.40719 C(01Q)-N(01I)-Ag(04) 125.39 
C(01L)-N(01M)  1.33317 C(02W)-N(01I)-Ag(04) 127.31 
N(01N)-C(02I)  1.34618 C(02W)-N(01I)-C(01Q) 106.412 
N(01N)-C(02L)  1.35319 N(00R)-C(01J)-N(00S) 109.812 
N(01N)-C(02Y)  1.49119 N(00B)-C(01K)-C(01Q) 112.612 
C(01P)-C(027)  1.382 O(00U)-C(01K)-N(00B) 119.712 
C(01Q)-C(01W)  1.38419 O(00U)-C(01K)-C(01Q) 127.713 
157 | P a g e  
 
C(01R)-C(01Y)  1.42518 N(00K)-C(01L)-N(00B) 121.811 
C(01R)-C(02M)  1.38319 N(00K)-C(01L)-N(01M) 121.312 
N(01S)-C(029)  1.402 N(01M)-C(01L)-N(00B) 116.811 
N(01S)-C(02F)  1.35919 C(02I)-N(01N)-C(02L) 109.912 
C(01U)-C(01X)  1.42018 C(02I)-N(01N)-C(02Y) 128.212 
C(01V)-C(02D)  1.38019 C(02L)-N(01N)-C(02Y) 119.912 
C(01X)-C(02I)  1.37319 N(00T)-C(01P)-N(00M) 126.612 
N(023)-C(02K)  1.372 N(00T)-C(01P)-C(027) 126.813 
N(023)-C(030)  1.482 C(027)-C(01P)-N(00M) 106.612 
C(024)-C(026)  1.422 N(01I)-C(01Q)-C(01K) 131.313 
C(027)-C(029)  1.392 C(01W)-C(01Q)-N(01I) 110.812 
C(02B)-N(02H)  1.402 C(01W)-C(01Q)-C(01K) 117.912 
C(02D)-C(039)  1.432 N(00N)-C(01R)-C(01Y) 129.412 
C(02F)-N(02Q)  1.362 N(00N)-C(01R)-C(02M) 110.011 
N(02H)-C(039)  1.392 C(02M)-C(01R)-C(01Y) 120.612 
N(02J)-C(02P)  1.33019 C(02F)-N(01S)-C(029) 126.313 
C(02R)-C(02T)  1.492 O(00D)-C(01U)-N(00H) 120.411 
C(02S)-C(035)  1.543 O(00D)-C(01U)-C(01X) 127.512 
C(02V)-O(036)  1.413 N(00H)-C(01U)-C(01X) 112.111 
C(02V)-C(03B)  1.513 N(00S)-C(01V)-N(01C) 126.712 
C(02X)-C(03D)  1.563 N(00S)-C(01V)-C(02D) 105.712 
C(02Z)-C(033)  1.533 N(01C)-C(01V)-C(02D) 127.613 
C(037)-C(038)  1.512 N(00K)-C(01W)-N(01E) 125.712 
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Crystal 8 
Bond Lengths (Å)   Bond Angles (°)   
Ag(01)-N(007)#1  2.203 N(5)-Ag(01)-N(007)#1 166.81 
Ag(01)-N(5)  2.153 N(17)#1-Ag(02)-N(00N) 164.61 
Ag(02)-N(00N)  2.183 F(00C)-Si(00)-F(00L) 88.211 
Ag(02)-N(17)#1  2.113 F(00C)-Si(00)-F(00P) 91.811 
Si(00)-F(00C)  1.662 F(00C)-Si(00)-F(00T) 89.412 
Si(00)-F(00I)  1.652 F(00C)-Si(00)-F(00Z) 87.711 
Si(00)-F(00L)  1.722 F(00I)-Si(00)-F(00C) 178.712 
Si(00)-F(00P)  1.692 F(00I)-Si(00)-F(00L) 93.011 
Si(00)-F(00T)  1.682 F(00I)-Si(00)-F(00P) 88.511 
Si(00)-F(00Z)  1.682 F(00I)-Si(00)-F(00T) 89.412 
N(007)-C(00E)  1.324 F(00I)-Si(00)-F(00Z) 92.111 
N(007)-C(00K)  1.405 F(00P)-Si(00)-F(00L) 89.611 
N(008)-C(00E)  1.344 F(00T)-Si(00)-F(00L) 177.513 
N(008)-C(012)  1.424 F(00T)-Si(00)-F(00P) 89.711 
O(009)-C(012)  1.234 F(00T)-Si(00)-F(00Z) 90.812 
O(00A)-C(00Q)  1.284 F(00Z)-Si(00)-F(00L) 89.811 
N(00B)-C(00V)  1.365 F(00Z)-Si(00)-F(00P) 179.212 
N(00B)-C(00W)  1.384 C(00E)-N(007)-Ag(01)#2 1242 
N(00B)-C(013)  1.484 C(00E)-N(007)-C(00K) 1143 
N(00D)-C(00E)  1.384 C(00K)-N(007)-Ag(01)#2 1212 
O(00F)-C(014)  1.394 C(00E)-N(008)-C(012) 1243 
O(00F)-C(017)  1.464 C(00V)-N(00B)-C(00W) 1063 
O(00G)-C(016)  1.414 C(00V)-N(00B)-C(013) 1323 
C(00J)-C(00K)  1.375 C(00W)-N(00B)-C(013) 1223 
C(00J)-C(012)  1.405 N(007)-C(00E)-N(008) 1253 
C(00J)-N(5)  1.394 N(007)-C(00E)-N(00D) 1203 
C(00K)-N(00O)  1.365 N(008)-C(00E)-N(00D) 1163 
O(00M)-C(013)  1.444 C(014)-O(00F)-C(017) 1162 
O(00M)-C(018)  1.443 C(00K)-C(00J)-C(012) 1233 
N(00N)-C(00V)  1.395 C(00K)-C(00J)-N(5) 1073 
N(00N)-C(010)  1.325 C(012)-C(00J)-N(5) 1293 
N(00O)-C(014)  1.435 C(00J)-C(00K)-N(007) 1223 
N(00O)-C(6)  1.374 N(00O)-C(00K)-N(007) 1283 
C(00Q)-C(00S)  1.445 N(00O)-C(00K)-C(00J) 1093 
C(00Q)-N(00X)  1.365 C(018)-O(00M)-C(013) 1122 
N(00R)-C(010)  1.355 C(00V)-N(00N)-Ag(02) 1252 
C(00S)-C(00V)  1.295 C(010)-N(00N)-Ag(02) 1232 
C(00S)-N(17)  1.384 C(010)-N(00N)-C(00V) 1133 
C(00W)-N(17)  1.364 C(00K)-N(00O)-C(014) 1273 
N(00X)-C(010)  1.385 C(00K)-N(00O)-C(6) 1043 
C(015)-C(017)  1.505 C(6)-N(00O)-C(014) 1283 
C(015)-O(20)  1.455 O(00A)-C(00Q)-C(00S) 1283 
C(016)-C(018)  1.515 O(00A)-C(00Q)-N(00X) 1213 
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Bond Lengths (Å)   Bond Angles (°)   
Ag(1)-N(6)  2.0995 N(6)-Ag(1)-N(1) 176.72 
Ag(1)-N(1)  2.1005 N(16)-Ag(2)-N(12) 177.03 
Ag(2)-N(16)  2.0905 F(3)-Si(1)-F(4) 88.92 
Ag(2)-N(12)  2.0905 F(3)-Si(1)-F(1) 87.42 
Si(1)-F(3)  1.6844 F(6)-Si(1)-F(3) 179.42 
Si(1)-F(6)  1.6784 F(6)-Si(1)-F(4) 90.72 
Si(1)-F(4)  1.6974 F(6)-Si(1)-F(1) 92.22 
Si(1)-F(2)  1.6534 F(4)-Si(1)-F(1) 88.72 
Si(1)-F(1)  1.6984 F(2)-Si(1)-F(3) 90.52 
Si(1)-F(5)  1.6584 F(2)-Si(1)-F(6) 89.92 
O(11)-C(27)  1.3957 F(2)-Si(1)-F(4) 177.72 
O(11)-C(28)  1.4247 F(2)-Si(1)-F(1) 89.13 
O(10)-C(24)  1.2247 F(2)-Si(1)-F(5) 93.23 
O(5)-C(6)  1.3928 F(5)-Si(1)-F(3) 91.72 
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O(5)-C(7)  1.4398 F(5)-Si(1)-F(6) 88.72 
O(2)-C(14)  1.3847 F(5)-Si(1)-F(4) 89.12 
O(2)-C(15)  1.4117 F(5)-Si(1)-F(1) 177.62 
N(9)-C(12)  1.3357 C(27)-O(11)-C(28) 111.25 
N(9)-C(11)  1.3297 C(6)-O(5)-C(7) 112.65 
N(18)-C(25)  1.3547 C(14)-O(2)-C(15) 115.45 
N(18)-C(26)  1.3188 C(11)-N(9)-C(12) 112.55 
N(8)-H(8A)  0.86 C(26)-N(18)-C(25) 112.25 
N(8)-H(8B)  0.86 H(8A)-N(8)-H(8B) 120 
N(8)-C(11)  1.3337 C(11)-N(8)-H(8A) 120 
N(10)-C(12)  1.3847 C(11)-N(8)-H(8B) 120 
N(10)-C(14)  1.4557 C(12)-N(10)-C(14) 126.25 
N(10)-C(13)  1.3737 C(13)-N(10)-C(12) 106.84 
O(4)-C(4)  1.2278 C(13)-N(10)-C(14) 127.05 
N(16)-C(23)  1.3898 C(23)-N(16)-Ag(2) 117.84 
N(16)-C(22)  1.3138 C(22)-N(16)-Ag(2) 137.04 
N(17)-C(27)  1.4667 C(22)-N(16)-C(23) 105.25 
N(17)-C(25)  1.3727 C(25)-N(17)-C(27) 126.35 
N(17)-C(22)  1.3727 C(25)-N(17)-C(22) 107.25 
O(9)-C(21)  1.2288 C(22)-N(17)-C(27) 126.35 
N(15)-H(15)  0.86 C(20)-N(15)-H(15) 123 
N(15)-C(20)  1.3298 C(20)-N(15)-C(19) 113.95 
N(15)-C(19)  1.3468 C(19)-N(15)-H(15) 123 
O(1)-C(10)  1.2368 C(13)-N(6)-Ag(1) 127.14 
N(6)-C(13)  1.3038 C(13)-N(6)-C(9) 105.35 
N(6)-C(9)  1.3957 C(9)-N(6)-Ag(1) 127.64 
N(3)-C(3)  1.3438 C(5)-N(3)-C(3) 112.05 
N(3)-C(5)  1.3069 H(14C)-N(14)-H(14D) 120 
N(14)-H(14C)  0.86 C(20)-N(14)-H(14C) 120 
N(14)-H(14D)  0.86 C(20)-N(14)-H(14D) 120 
N(14)-C(20)  1.3178 C(26)-N(19)-H(19) 117.3 
N(19)-H(19)  0.86 C(26)-N(19)-C(24) 125.45 
N(19)-C(26)  1.3928 C(24)-N(19)-H(19) 117.3 
N(19)-C(24)  1.4038 C(20)-N(13)-H(13A) 116.9 
N(13)-H(13A)  0.86 C(20)-N(13)-C(21) 126.26 
N(13)-C(20)  1.3737 C(21)-N(13)-H(13A) 116.9 
N(13)-C(21)  1.3989 C(3)-N(2)-C(6) 126.45 
N(2)-C(3)  1.3768 C(1)-N(2)-C(3) 106.75 
N(2)-C(6)  1.4687 C(1)-N(2)-C(6) 126.86 
N(2)-C(1)  1.3678 C(2)-N(1)-Ag(1) 118.44 
N(1)-C(2)  1.3899 C(1)-N(1)-Ag(1) 136.65 
N(1)-C(1)  1.3108 C(1)-N(1)-C(2) 105.05 
N(7)-H(7)  0.86 C(11)-N(7)-H(7) 117.2 
N(7)-C(11)  1.3747 C(11)-N(7)-C(10) 125.65 
N(7)-C(10)  1.3918 C(10)-N(7)-H(7) 117.2 
O(14)-H(14E)  0.8494 H(14E)-O(14)-H(14F) 109.6 
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O(14)-H(14F)  0.8497 C(16)-O(3)-H(3) 109.5 
O(3)-H(3)  0.82 H(20A)-N(20)-H(20B) 120 
O(3)-C(16)  1.3809 C(26)-N(20)-H(20A) 120 
N(20)-H(20A)  0.86 C(26)-N(20)-H(20B) 120 
N(20)-H(20B)  0.86 C(18)-N(12)-Ag(2) 125.55 
N(20)-C(26)  1.3348 C(17)-N(12)-Ag(2) 127.85 
N(12)-C(18)  1.3929 C(17)-N(12)-C(18) 106.36 
N(12)-C(17)  1.32612 N(9)-C(12)-N(10) 125.85 
C(12)-C(9)  1.3798 N(9)-C(12)-C(9) 128.95 
C(27)-H(27A)  0.97 C(9)-C(12)-N(10) 105.35 
C(27)-H(27B)  0.97 O(11)-C(27)-N(17) 112.84 
O(8)-C(01S)  1.3209 O(11)-C(27)-H(27A) 109 
O(8)-C(022)  1.4199 O(11)-C(27)-H(27B) 109 
C(14)-H(14A)  0.97 N(17)-C(27)-H(27A) 109 
C(14)-H(14B)  0.97 N(17)-C(27)-H(27B) 109 
O(15)-H(15C)  0.8498 H(27A)-C(27)-H(27B) 107.8 
O(15)-H(15D)  0.8496 C(01S)-O(8)-C(022) 114.67 
C(25)-C(23)  1.3768 O(2)-C(14)-N(10) 112.95 
C(23)-C(24)  1.4159 O(2)-C(14)-H(14A) 109 
C(13)-H(13)  0.93 O(2)-C(14)-H(14B) 109 
N(4)-H(4)  0.86 N(10)-C(14)-H(14A) 109 
N(4)-C(4)  1.3929 N(10)-C(14)-H(14B) 109 
N(4)-C(5)  1.3758 H(14A)-C(14)-H(14B) 107.8 
C(9)-C(10)  1.4198 N(9)-C(11)-N(8) 120.55 
C(3)-C(2)  1.3768 N(9)-C(11)-N(7) 123.05 
C(21)-C(18)  1.3961 N(8)-C(11)-N(7) 116.55 
C(6)-H(6A)  0.97 N(15)-C(20)-N(13) 121.75 
C(6)-H(6B)  0.97 N(14)-C(20)-N(15) 120.25 
C(18)-C(19)  1.3918 N(14)-C(20)-N(13) 118.15 
O(7)-H(7C)  0.82 H(15C)-O(15)-H(15D) 104.7 
O(7)-C(021)  1.45002 N(18)-C(25)-N(17) 126.55 
C(19)-N(11)  1.3849 N(18)-C(25)-C(23) 127.95 
C(2)-C(4)  1.4009 N(17)-C(25)-C(23) 105.55 
N(5)-H(5A)  0.86 N(16)-C(23)-C(24) 129.05 
N(5)-H(5B)  0.86 C(25)-C(23)-N(16) 110.25 
N(5)-C(5)  1.3431 C(25)-C(23)-C(24) 120.85 
C(16)-H(16A)  0.97 N(18)-C(26)-N(19) 123.75 
C(16)-H(16B)  0.97 N(18)-C(26)-N(20) 120.85 
C(16)-C(15)  1.4611 N(20)-C(26)-N(19) 115.45 
C(22)-H(22)  0.93 N(10)-C(13)-H(13) 123.8 
N(11)-C(01S)  1.6021 N(6)-C(13)-N(10) 112.55 
N(11)-C(17)  1.3809 N(6)-C(13)-H(13) 123.8 
C(7)-H(7A)  0.97 C(4)-N(4)-H(4) 117.2 
C(7)-H(7B)  0.97 C(5)-N(4)-H(4) 117.2 
C(7)-C(8)  1.4761 C(5)-N(4)-C(4) 125.66 
C(15)-H(15A)  0.97 N(6)-C(9)-C(10) 131.15 
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C(15)-H(15B)  0.97 C(12)-C(9)-N(6) 110.15 
C(01S)-H(01A)  0.97 C(12)-C(9)-C(10) 118.75 
C(01S)-H(01B)  0.97 N(3)-C(3)-N(2) 126.25 
C(28)-H(28A)  0.97 N(3)-C(3)-C(2) 128.06 
C(28)-H(28B)  0.97 N(2)-C(3)-C(2) 105.86 
C(28)-C(29)  1.50311 O(10)-C(24)-N(19) 121.76 
C(1)-H(1)  0.93 O(10)-C(24)-C(23) 128.36 
C(8)-H(8AA)  0.97 N(19)-C(24)-C(23) 110.05 
C(8)-H(8AB)  0.97 O(9)-C(21)-N(13) 120.07 
C(8)-H(8BC)  0.97 O(9)-C(21)-C(18) 128.77 
C(8)-H(8BD)  0.97 C(18)-C(21)-N(13) 111.25 
C(8)-O(6A)  1.45002 O(5)-C(6)-N(2) 112.15 
C(8)-O(6B)  1.45002 O(5)-C(6)-H(6A) 109.2 
O(12)-H(12)  0.82 O(5)-C(6)-H(6B) 109.2 
O(12)-C(29)  1.42013 N(2)-C(6)-H(6A) 109.2 
C(021)-H(02A)  0.97 N(2)-C(6)-H(6B) 109.2 
C(021)-H(02B)  0.97 H(6A)-C(6)-H(6B) 107.9 
C(021)-C(022)  1.50112 N(12)-C(18)-C(21) 131.36 
C(022)-H(02C)  0.97 C(19)-C(18)-N(12) 108.66 
C(022)-H(02D)  0.97 C(19)-C(18)-C(21) 119.96 
C(17)-H(17)  0.93 C(021)-O(7)-H(7C) 109.5 
C(29)-H(29A)  0.97 N(15)-C(19)-C(18) 126.86 
C(29)-H(29B)  0.97 N(15)-C(19)-N(11) 126.16 
O(6A)-H(6AA)  0.82 N(11)-C(19)-C(18) 107.06 
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O(7)-C(021)-H(02B) 109.7 
  
O(7)-C(021)-C(022) 109.76 
  
H(02A)-C(021)-H(02B) 108.2 
  
C(022)-C(021)-H(02A) 109.7 
  
C(022)-C(021)-H(02B) 109.7 
  
O(8)-C(022)-C(021) 107.67 
  
O(8)-C(022)-H(02C) 110.2 
  
O(8)-C(022)-H(02D) 110.2 
  
C(021)-C(022)-H(02C) 110.2 
  
C(021)-C(022)-H(02D) 110.2 
  
H(02C)-C(022)-H(02D) 108.5 
  
N(12)-C(17)-N(11) 111.97 
  
N(12)-C(17)-H(17) 124.1 
  
N(11)-C(17)-H(17) 124.1 
  
C(28)-C(29)-H(29A) 109.7 
  
C(28)-C(29)-H(29B) 109.7 
  
O(12)-C(29)-C(28) 109.97 
  
O(12)-C(29)-H(29A) 109.7 
  
O(12)-C(29)-H(29B) 109.7 
  
H(29A)-C(29)-H(29B) 108.2 
  
C(8)-O(6A)-H(6AA) 109.5 
  
C(8)-O(6B)-H(6BA) 109.5 
Table 30 
